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In the United States, 30% of kidney transplant (KT) recipients experience early hospital 
readmission (EHR), or readmission within 30 days of discharge following transplantation. Known 
predictors of EHR include older age, African American race, comorbidity, and increased length 
of stay, and EHR is associated with inferior patient and graft survival.  
 
To broaden our understanding of EHR in transplantation, we began with a prospective cohort 
study of EHR among KT recipients at Johns Hopkins Hospital. We used granular clinical data to 
characterize clinical scenarios leading to EHR. We also explored the association between EHR 
and novel predictors, including cognitive function, physical function, and socioeconomic factors.  
 
Next, we used national data to further explore novel predictors of EHR and to determine whether 
the risk of adverse outcomes associated with EHR varies over time. We used County Health 
Rankings and U.S. Census data to quantify the association between EHR and social determinants 
of health. We then estimated the association between EHR and adverse outcomes for two distinct 
time periods: during the EHR hospitalization and post-EHR. Finally, we used national data to 
develop a risk prediction model for EHR following simultaneous pancreas-kidney (SPK) 
transplantation and to quantify the association between EHR and post-SPK outcomes.  
 
At our center, we found that a high number of KT recipients are readmitted directly to the 
hospital without prior evaluation by a healthcare provider. Using national data, we found that 
living in a high-risk community increases the risk of EHR, but socioeconomic status was not 
associated with EHR. Following SPK, we found that 55% of recipient experience EHR. EHR 
following SPK was associated with younger recipient age, African American donor, and length of 
stay. We also found that EHR, following both KT and SPK, was most strongly associated with 
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graft loss and mortality during the readmission hospitalization, but also portends a lasting, albeit 
attenuated, risk post-readmission.  
 
Our future plans include the development of a clinical prediction tool to assess recipient risk of 
EHR prior to transplant discharge. We plan to develop of clinical strategies and outpatient 














Dr. Dorry Segev, Professor, Clinical Investigations, Surgery 
Dr. Jennifer Dodson, Assistant Professor, Clinical Investigations, Urology 
Dr. James Tonascia, Professor, Biostatistics 
Dr. Charles Flexner, Professor, Clinical Investigations, Clinical Pharmacology 
Dr. Niraj Desai, Assistant Professor, Surgery 
Dr. Brian Caffo, Professor, Biostatistics 
Dr. Marie Diener-West, Professor, Biostatistics
iv	
	
TABLE OF CONTENTS 
 
ABSTRACT……………………………………………………………………………………….ii 
TABLE OF CONTENTS………………………………………………………………………….iv 
LIST OF TABLES…………………………………………………………………………………v 
LIST OF FIGURES………………………………………………………………………………vii 
INTRODUCTION…………………………………………………………………………………1 
CHAPTER 1: READMISSION FOLLOWING KIDNEY TRANSPLANTATION – SINGLE 
CENTER…………………………………………………………………………………………...4 
CHAPTER 2: SOCIAL DETERMINANTS OF HEALTH AND READMISSION……………..28 
CHAPTER 3: IMPACT OF READMISSION FOLLOWING KIDNEY 
TRANSPLANTATION…………………………………………………………………………..44 
CHAPTER 4: READMISSION FOLLOWING SIMULTANEOUS PANCREAS-KIDNEY 
TRANSPLANTAION…………………………………………………………………………….57 
CHAPTER 5: IMPACT OF READMISSION FOLLOWING SIMULTANEOUS  
PANCREAS-KIDNEY TRANSPLANTATION…………………………………………………77 
DISCUSSION AND FUTURE PLANS………………………………………………………….88 
REFERENCES…………………………………………………………………………………...92 
BIBLIOGRAPHY……………………………………………………………………………….105 





LIST OF TABLES 
 
1.1: Study population characteristics, by early hospital readmission, n=400.           17 
1.2: Route of readmission.                 18 
1.3: Recipient characteristics, by route of readmission.                                                                 19 
1.4: Reason for readmission.                  20 
1.5: Health related quality of life, cognitive impairment, functional dependence, and physical 
disability, by early hospital readmission.                                        22 
1.6: Unadjusted relative risk of early hospital readmission following kidney transplantation, by 
each novel predictor.                   22 
1.7: Adjusted relative risk of early hospital readmission following kidney transplantation.          23 
1.8: Socioeconomic factors, by early hospital readmission.             24 
2.1: Study population characteristics, by community risk score, n=52,738.                  39 
2.2: Relative risk of early hospital readmission following kidney transplantation, by social 
determinants of heath.                  41 
2.3: Relative risk of early hospital readmission following kidney transplantation, by each 
component of the community risk score.                            42 
2.4: Relative risk of early hospital readmission following kidney transplantation, by each 
component of the socioeconomic status index.               43 
3.1: Study population characteristics, by early hospital readmission, n=56,076.           53 
3.2: Hazard of death-censored graft loss and mortality during early hospital readmission       
hospitalization (readmission hospitalization) and following early hospital readmission discharge 
(post-readmission).                  54 
4.1: Study population characteristics, by early hospital readmission (EHR).                                 70 
4.2: Reason for early hospital readmission after simultaneous pancreas kidney transplantation, 
n=2,021.                   72 
vi	
	
4.3: Relative risk of early hospital readmission after simultaneous pancreas-kidney 
transplantation, n=3,643.                                                                                                                 73 
4.4: Relative risk of early hospital readmission after simultaneous pancreas-kidney 
transplantation by center-level factors, n=3,643.               74 
5.1: Study population characteristics, by early hospital readmission, n=3,054.                     86 
5.2: Hazard of death-censored graft loss and mortality during readmission hospitalization 




LIST OF FIGURES 
 
1.1: Percent of kidney transplant recipients experiencing early hospital readmission by day  
since discharge following transplantation.               25 
1.2: Length of stay for early hospital readmission hospitalization.               26 
1.3: Proportion of direct admissions from home by time of day.             27 
3.1: Hazard ratio of post-readmission death-censored graft loss over time, comparing readmitted 
to non-readmitted (reference) (A) deceased donor (DDKT) and (B) live donor (LDKT) kidney 
transplant recipients.                           55 
3.2: Hazard ratio of post-readmission mortality over time, comparing readmitted to non-
readmitted (reference) (A) deceased donor (DDKT) and (B) live donor (LDKT) kidney  
transplant recipients.                  56 
4.1: Ratio of observed to expected probability of early hospital readmission after simultaneous 
pancreas-kidney transplantation for each transplant center.                         75 
4.2: Relative risk of early hospital readmission after simultaneous pancreas-kidney 






Early hospital readmission (EHR), defined as readmission within 30 days of initial discharge, is a 
known predictor of potentially avoidable morbidity, mortality, and cost. EHR is increasingly used 
a marker of healthcare quality. In 2009, the Centers for Medicare and Medicaid Services (CMS) 
began publicly reporting hospital readmission rates to motivate clinical practices that reduce 
EHR. In 2012, CMS began the Hospital Readmission Reduction Program (HRRP), which 
financially penalizes hospitals with higher than expected rates of readmission. However, critics of 
the HRRP argue that the majority of readmissions may not be preventable and many readmissions 
actually represent good clinical care. A comprehensive understanding of EHR will enable more 
appropriate clinical practice and guide future healthcare policy.  
 
Following general surgical procedures, readmission is as high as 22%. Identified risk factors for 
readmission include comorbidity, length of stay, and surgical complications, and EHR is 
associated with increased postoperative mortality. Following kidney transplantation, 31% of KT 
recipients experience EHR. Many argue that KT is surgically complex and EHR is a marker of 
clinical complexity rather than inferior quality. However, there is a high level of variability in the 
rate of readmission across transplant centers, ranging from 18-47%.  
 
To understand EHR following KT, it is first necessary to identify, which patients are at highest 
risk of readmission. Using national data, our group previously identified 19 patient-level 
characteristics associated with EHR. Recipient factors included African American race and 
various comorbidities, while transplant factors included extended criteria donor, lack of induction 
immunosuppression, and increased length of stay. Despite these patient-level associations, it 
remains difficult to predict which patients will experience EHR, and even after adjusting for 
clinical characteristics, there is still wide variation in the incidence of EHR across transplant 
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centers. Factors above and beyond clinical predictors, including healthcare practices, 
socioeconomic factors, and the environment in which the patient lives, may contribute to EHR.  
 
To better address EHR, we must understand the immediate and long-term impact of readmission 
on post-transplant outcomes. Our group showed that recipients experiencing EHR are more likely 
to experience late hospital readmission or subsequent readmission within the first-year post-
transplant. In addition, KT recipients with EHR have an increased risk of death-censored graft 
loss and mortality. Although EHR increases the risk of adverse outcomes, the timeline of risk is 
unclear. Understanding the attributable risk associated with EHR during different time periods, 
specifically the EHR hospitalization and post-EHR, may help guide clinical management. 
 
Little is known about EHR following simultaneous pancreas-kidney transplantation (SPK), which 
is an important treatment option for Type 1 diabetics with end stage renal disease. SPK is 
surgically more complex and the incidence and risk profile associated with EHR may be unique 
given the increased complexity. Existing studies suggest readmission is much more common 
among SPK recipients, but fail to identify relevant risk factors for EHR and have yet to classify 
the impact of EHR following SPK.  
 
The goals of this thesis were to identify systematic mechanisms of EHR, to provide transplant 
providers with a more comprehensive profile of recipients at risk of EHR, and to accurately 
quantify the impact of EHR on long-term post-transplant outcomes. Chapter 1 describes the 
clinical scenarios surrounding EHR using granular clinical data from our transplant center. 
Chapter 1 also explores novel risk predictors for EHR including health related quality of life, 
cognitive function, functional status, physical disability, socioeconomic factors, and 
desensitization. Chapter 2 quantifies the association between EHR and social determinants of 
health, assessing the effect of community risk, socioeconomic status, residential status, and 
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distance from transplant center on EHR. Chapter 3 evaluates the association between EHR and 
post-KT survival, isolating the risk associated with EHR during the EHR hospitalization and the 
risk post-EHR. Chapter 4 explores the incidence of EHR following SPK and quantifies the 
association between patient-level characteristics and EHR. Finally, Chapter 5 quantifies the 
impact of EHR on post-SPK survival.  
 
We hope this thesis work will guide development of interventions that can effectively mitigate the 








Based on national data, 30% of kidney transplant recipients experience early hospital 
readmission. Unfortunately, registry data lack the granularity to identify mechanisms of 
readmission and risk factors beyond clinical characteristics. The purpose of this study was to 
broaden our understanding of 30-day readmissions through an in-depth analysis of single-center 
data. We studied 400 adult, kidney-only transplant recipients from May 1, 2012- April 30, 2014. 
Modified Poisson regression was used to estimate the association between readmission and novel 
predictors (health related quality of life, cognitive function, functional status, physical function, 
socioeconomic factors, and desensitization). Interestingly, 40.8% of recipients experiencing 
readmission were readmitted directly from home. The most common reason for readmission was 
infection (24.2%), however 16% of readmitted recipients had two or more primary reasons for 
readmission. Readmission was not associated with health-related quality of life, cognitive 
function, functional status, physical function, socioeconomic factors, or desensitization. 
Readmission was associated with temporary housing during the immediate post-transplantation 
period (aRR 1.562.564.20, p<0.001). At our center, almost half of readmissions occurred directly 
from home, without prior evaluation by a healthcare provider. The reasons for readmission were 






National registry data demonstrate that 31% of kidney transplant recipients experience early 
hospital readmission (EHR), or readmission within 30 days of initial discharge after kidney 
transplantation (KT) (1). Based on this data, we recently identified recipient and transplant factors 
that increase the risk of EHR, including advanced age, African American race, obesity, diabetes, 
time on dialysis, extended criteria donor (ECD), donation after cardiac death (DCD), and length 
of stay greater than 5 days (1). EHR has a significant impact on post-transplant outcomes, such 
that EHR is associated with inferior graft and patient survival (2). Unfortunately, national registry 
data are unable to capture more granular details about recipients experiencing readmission and 
the readmission process itself. As such, we have been unable to investigate patient-level 
contributors, beyond clinical characteristics, that may have an important impact on EHR. 
 
Single center studies can be very useful for identifying clinical details and processes not captured 
in registry data. With respect to EHR, single center studies have already provided a more 
comprehensive understanding of medical reasons for readmission and an initial understanding of 
which readmissions may be preventable (3-5). For example, in a single center study of 462 KT 
recipients, Lubetzkety et al. established that 20.7% of readmissions were due to issues with the 
surgical site and that 11.7% of readmitted recipients had a medical issue at the time of initial 
discharge that ultimately lead to readmission (3). Another study of 753 KT recipients used single 
center data to show that a mere 8% of readmissions were preventable (4). Single center data can 
also provide more granular details about patient-level risk factors. Our own group used single 
center data to demonstrate an association between frailty and EHR. Frail KT recipients were 
much more likely to experience EHR (45.8% vs. 28.0%, p = 0.005) (5). Many patient-level 
characteristics that contribute to post-transplant outcomes are impractical to measure nationally. 
In particular, factors such as health related quality of life (HRQOL), cognitive and physical 
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function, and socioeconomic status are not captured by national registries, but may contribute to 
EHR. Single center data may be necessary to broaden our understanding of EHR.  
 
To better predict which recipients are at risk of EHR and to understand the mechanism through 
which EHR occurs, we performed a single center prospective study of EHR following KT at our 
high volume center. The objective of this study was to characterize the route of readmission and 
to quantify the association between EHR and novel predictors including HRQOL, cognitive and 




This was a prospective cohort study of 251 adult kidney-only transplant recipients, supplemented 
with data from a retrospective cohort of 149 adult kidney-only transplant recipients, for a total 
study population of 400 recipients that underwent transplantation at Johns Hopkins Hospital, 
Baltimore, Maryland between May 1, 2012 and April 30, 2014. Two recipients died within 30 
days following discharge after KT; one was not readmitted prior to death and was excluded from 
the study. The other was readmitted prior to death and therefore was included in the study. 
Recipient, donor, and transplant characteristics (age, sex, race, body mass index (BMI), diabetes, 
hepatitis C seropositivity, time on dialysis, donor type, KT length of stay) were ascertained from 
medical records. The Johns Hopkins Institutional Review Board approved this study.  
 
Ascertainment of Exposures 
HRQOL, cognitive function, activities of daily living/instrumental activities of daily living 
(ADLs/IADLs), and physical function were prospectively assessed immediately prior to KT. 
These exposures were measured on 251 of the 400 participants. HRQOL was assessed using a 
single question from the Kidney Disease Quality of Life (KDQOL) instrument: “In general would 
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you say your health is…” The question is answered on a 5-point Likert scale (“excellent”, “very 
good”, “good”, “fair”, or “poor”) (6). Cognitive function was assessed using the Modified Mini 
Mental State (3MS) test. Total scores of the 3MS range from 0 to 100 with lower scores 
indicative of a higher level of cognitive impairment. Scores <79 are indicative of some cognitive 
impairment and scores <48 are indicative of severe cognitive impairment (7). ADLs were self-
reported by recipients based on the Katz ADL Index, which assesses six different tasks: bathing, 
dressing, toileting, transferring, continence, and feeding. A point is given for each task that can be 
carried out by the recipient without assistance. The sum ADL score ranges from 0 to 6, and lower 
scores are indicative of a higher level of functional dependence (8). A priori, ADL functional 
dependence was defined as requiring assistance with one or more task, or a score less than or 
equal to 5. IADLs were self-reported by recipients based on the Lawton IADL scale, which 
assesses eight tasks: ability to use the telephone, shopping, food preparation, housekeeping, 
laundry, mode of transportation, responsibility for own medication, and ability to handle finances. 
The sum IADL score ranges from 0 to 8, and lower scores are indicative of a higher level of 
functional dependence (9). A priori, IADL functional dependence was defined as requiring 
assistance with one or more tasks, or a score less than or equal to 7. Physical function was 
assessed using two measures: the Short Battery of Physical Performance (SBPP) and grip 
strength. The SBPP includes an assessment of standing balance, a timed 8-foot walk at normal 
pace, and a timed test of 5 repetitions of rising from a chair and sitting down. The sum score 
ranges from 0 to 12, with lower scores indicating worse physical function (10). A priori, physical 
disability was defined as a score less than 8 on the SBPP. Grip strength was directly measured 
and adjusted for gender and BMI to give a grip strength rating with higher values indicating more 
strength (11).  
 
Economic factors (fixed income, employment status, insurance status, financial issues) and social 
factors (marital status, education level, cohabitants, intravenous drug use (IVDU), and legal 
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issues) were ascertained from medical records. We also identified patients who, because of 
traveling from out of town for transplantation at Johns Hopkins, arranged temporary housing in 
Baltimore during their convalescence instead of recovering at home. 
 
Ascertainment of Outcome 
Early hospital readmission was defined as any hospitalizations within 30 days of initial discharge 
following kidney transplantation, as done in our previous national studies (1, 2, 5, 12). At the 
time of readmission, the nurse practitioner caring for each recipient was asked to document the 
route of readmission and reason for readmission. Missing information about route and reason 
were ascertained through medical record abstraction. Two physicians performed independent 
review of each readmission to resolve any discrepancies and to determine a single primary reason 
for readmission. For recipients readmitted more than once in the 30-day period following KT 
discharge, the reason and route for their first readmission were used.  
 
The route of readmission was empirically classified into one of six categories: direct admission 
from home, admission from the emergency department, admission from clinic, transfer from an 
outside hospital, transfer from a rehabilitation center, or other route. Route of readmission was 
also treated as a binary outcome to compare direct admission from home to admission via any 
other route. The decision to admit directly from home would have occurred without physical 
evaluation of the recipient by a healthcare provider, and was therefore treated as mechanistically 
distinct compared to any other route of readmission.  
 
The reason for readmission was empirically classified into one of ten categories: infection, 
gastrointestinal disorder, fluid collection, hyperkalemia, graft rejection, volume overload, cardiac 
complication, genitourinary disorder/procedure, desensitization protocol, or other. The 
desensitization protocol category captures readmissions due to routine care of recipients that 
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received an incompatible KT. For patients who were found to have more than one reason for 
readmission, the two physician abstractors discussed each clinical scenario and agreed upon the 
most likely inciting reason for readmission. 
 
Statistical Analysis 
We compared differences in novel predictors between recipients experiencing EHR and recipient 
without EHR using t-tests for psuedonormally distributed continuous variables and chi-squared 
tests for categorical variables. The relative risk of EHR associated with each novel predictor was 
estimated using modified Poisson regression as previously described (13). Each predictor was 
first explored in a univariate model. Predictors that were statistically significant on univariate 
analysis were included in a final model adjusted for patient-level characteristics. For optimal 
parsimony, we adjusted the final model for recipient, donor, and transplant characteristics based 
on predictors of EHR in the national registry-based model including age, African American race, 
BMI, diabetes, time on dialysis, HCV, donor type, and length of stay (1). Functional forms for 
continuous variables were based on exploratory data analysis. Health related quality of life was 
dichotomized as “good” HRQOL or better and “fair” HRQOL or worse. Education level was 
dichotomized to compare high school education or less with any college education. Our center 
has a high proportion of KT recipients that require desensitization. A sub-group analysis was 
performed to characterize EHR among recipients undergoing desensitization. Confidence 
intervals are reported as per the methods of Louis and Zeger, as previously described (14, 15). All 




Among the 400 KT recipients in this study, 120 (30%) had at least one EHR. Median time to 
EHR was 9 days (IQR 6-16), with 5% experiencing EHR within 3 days of discharge after KT, 
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11.6% within 7 days, and 21% within 14 days of discharge (Figure 1.1). The median length of the 
EHR hospitalization was 5 days (IQR 3-9) (Figure 1.2). The median age of recipients was 55 
years (IQR 43.5-65), 44.8% were female, and 38.5% were African American (Table 1.1).  
 
Route of EHR 
The most common route of readmission was direct admission from home (40.8%) (Table 1.2). 
The proportion of patients directly readmitted from home was highest during the evening hours, 
with a nadir around midnight (Figure 1.3). When comparing recipients who were directly 
readmitted to those readmitted by any other route, there was no difference in age, sex, race, public 
insurance, transplant or readmission length of stay, or distance from transplant center (Table 1.3). 
A higher proportion of directly readmitted recipients had temporary housing, a finding that 
approached statistical significance on univariate analysis (26.5% vs. 12.7%, p=0.054). 
 
Reason for EHR 
The most common reason for EHR was infection (24.2%), followed by gastrointestinal 
complications (14.2%), and fluid collection (14.0%) (Table 1.4). Among those readmitted for 
infectious concerns, the most frequent causes were urinary tract infection (55.2%), bacteremia 
(17.1%), wound infection (13.8%), and clostridium dificile colitis (6.9%). Hyperkalemia 
comprised 9.2% of readmissions, with 9.1% of hyperkalemic recipients requiring inpatient 
dialysis. Another common reason for readmission was rejection. A total of 8.3% of recipients 
were readmitted for rejection. Among recipients readmitted for rejection, 90% had undergone 
desensitization. The “other” category included hyperglycemia, altered mental status, bleeding, 
gout, and fractures. Although categories were based on the single dominant reason for EHR, 





HRQOL and EHR 
Among participants that had HRQOL measured, 9.3% reported “excellent” HRQOL, 16.2% 
reported “very good” HRQOL, 40.5% reported “good” HRQOL, 26.3 reported “fair” HRQOL, 
and 7.7% reported “poor” HRQOL (Table 1.5). In univariate analysis, having HRQOL reported 
as “good” or better was not associated with EHR (0.490.991.98, p=0.9) (Table 1.6).  
 
Cognitive Function and EHR 
Among participants that had cognitive function measured, the median MMSE score was 94 (IQR 
90-98) (Table 1.5). In univariate analysis, cognitive impairment (MMSE score<79) was not 
associated with EHR (0.430.861.75, p=0.7) (Table 1.6). 
 
ADLs/IADLs and EHR 
The median ADL score was 6 (IQR 6-6). ADL functional dependence, or an ADL score <6, was 
present in 10.5% of recipients (Table 1.5). In an unadjusted regression model, ADL functional 
dependence was associated with a 1.56-fold increase in the risk of EHR (RR 1.021.562.40, p=0.04) 
(Table 1.6). In a multivariate model adjusted for recipient, donor, and transplant characteristics, 
ADL functional dependence was no longer associated with EHR (aRR 0.901.492.47, p=0.8) (Table 
1.7).  
 
The median IADL score was 8 (IQR 8-8). IADL functional dependence, or an IADL score <8, 
was present in 11.7% of recipients (Table 1.5). In an unadjusted regression model, IADL 







Physical Function and EHR 
The median SBPP score was 11 (IQR 9-12). SBPP disability, or a score <8, was present in 1.3% 
of recipients (Table 1.5). In an unadjusted regression model, SBPP disability was not associated 
with EHR (RR 0.451.344.00, p=0.6) (Table 1.6). 
 
The median grip strength rating was 21 (15-30) (Table 1.5). In an unadjusted regression model, 
grip strength rating was not associated with EHR (RR 0.980.991.01, p=0.4) (Table 1.6).  
 
Socioeconomic Factors and EHR 
Recipients experiencing EHR were similar to recipients without EHR with regard to most 
socioeconomic factors (Table 1.7). In univariate analysis, public insurance was associated with a 
1.36-fold increase in the risk of EHR (RR 1.011.361.84, p=0.046) (Table 1.6). In univariate analysis, 
temporary housing was associated with a 1.86-fold increase in the risk of EHR (RR 1.331.862.61, 
p<0.001) (Table 1.6). No other socioeconomic factors were associated with EHR, including 
marital status, education level, employment status, mental health issues, drug use, or legal or 
financial issues. In a multivariate model adjusted for recipient, donor, and transplant 
characteristics, the association between EHR and temporary housing was even stronger, such that 
temporary housing was associated with a 2.56-fold increase in the risk of EHR (aRR 1.562.564.19, 
p<0.001) (Table 1.7). 
 
Desensitization and EHR 
Desensitization was used for 28.6% of recipients. There was no significant difference in the crude 
incidence of EHR for recipients that underwent desensitization (35.5%) compared to other KT 
recipients (27.9%) (p=0.1). Among live donor KT recipients, desensitized recipients had a higher 
incidence of EHR (33.3%) compared to other live donor recipients (19.6%), a finding that 
approached statistical significance (p=0.08). Compared to other KT recipients experiencing EHR, 
13	
	
desensitized recipients were more likely to be readmitted for rejection (23.7% compared to 1.2%, 
p<0.001). Two desensitized recipients were readmitted for procedures that are part of our 
desensitization protocol, specifically gamma globulin infusion and replacement of a pheresis 
catheter. Compared to other KT recipients, desensitized recipients were more likely to be 
readmitted directly to the hospital without prior evaluation by a healthcare provider (55.3% 
compared to 34.2%, p=0.03). 
 
DISCUSSION 
In this single center study 30% of KT recipients experienced EHR. Direct admission from home 
was the route of readmission for 40.8% of recipients. Infection was the most common reason for 
readmission and 55.2% of infections were urinary tract infections. EHR was not associated with 
HRQOL, cognitive function, functional status, or physical function, although there was an 
association between EHR and ADL functional dependence on univariate analysis. Recipients with 
partial or total functional dependence (requiring assistance with at least one ADL) were at a 1.56-
fold increased risk of EHR. Readmission was not associated with socioeconomic factors. 
However, readmission was associated with temporary housing. Recipients convalescing near the 
transplant center were at a 2.56-fold increased risk of EHR. The crude incidence of EHR among 
desensitized recipients was no different than the incidence for all other recipients or the incidence 
for other live donor recipients. Desensitized recipients experiencing readmission were more likely 
to be readmitted directly to the hospital and were more likely to be readmitted for rejection 
compared to all other recipients experiencing EHR.  
 
To our knowledge, this is the first study to evaluate the route of hospital admission in the context 
of EHR. Nationally, direct hospital admission only accounts for about 15% of all non-elective 
adult hospitalizations (16). In our study, direct hospital admission was more common, occurring 
in 40.8% of readmissions. KT recipients require very specialized care immediately following 
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transplantation and they are monitored very closely as outpatients. Compared to other patients, 
KT recipients may maintain more frequent contact with their providers and may be less likely to 
present to the emergency department or another outpatient setting.  
 
A strength of this study is that the reason for each readmission was ascertained directly from 
transplant providers or through medical record abstraction. Comprehensive evaluation of each 
readmission enabled us to more accurately determine the primary diagnosis. The most common 
reason for EHR was infection (24.2%) and the urinary tract was the most common source 
(55.2%). Our previous national model of EHR following KT showed 36% of readmissions were 
due to a kidney, ureter, prostate, or bladder procedure and only 12% of EHR was due to infection 
(1). However, that study was performed using Medicare claims data, which provides only broad 
categories for diagnoses and does not take into account the possibility of multiple reasons for one 
readmission. In another large single-center study of 201 KT recipients, Harhay et al. showed that 
10.4% of readmissions were due to infection. Another 16.9% of readmissions were due to 
surgical complication, which included wound complications (4). In our study, wound 
complications due to infection were classified as infection.  
 
We found that functional dependence, as measured through ADLs may be associated with an 
increased risk of EHR, although the association disappeared on multivariate analysis likely due to 
low sample size. The association is consistent with studies of functional dependence and 
readmission following other surgeries (17-19). In a study using National Surgical Quality 
Improvement Program (NSQIP) data for 10,112 patients undergoing joint athroplasty, partial or 
total functional dependence was associated with a 1.70-fold increase in EHR (17). Another study 
using NSQIP data found that among 35,655 patients that underwent laparoscopic weight-loss 
surgery, partial or total dependence was associated with a 1.94-fold increase in the risk of 
readmission (19). Health related quality of life and other measures of functional status were not 
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associated with EHR. One potential explanation is that candidates for KT are selected based on 
many of these same characteristics and our study population was relatively homogeneous with 
regard to HRQOL, cognitive function, and physical function. 
 
Among desensitized recipients, the incidence of EHR was no different from other KT recipients. 
We might expect that desensitized recipients would be readmitted with increased frequency due 
the added complexity of desensitization, including changes in antibody status or issues with 
pheresis. The lack of difference may be attributable to the fact that in a center where many 
patients undergo desensitization we have outpatient resources in place for biopsies, antibody 
testing, and pheresis. In addition, these patients are monitored very closely as outpatients, and 
problems may be identified and treated early before they necessitate readmission.  
 
Our study has several notable limitations. The results may not be generalizable given that 
transplant centers vary with respect to patient population and practice paradigms. However, our 
study population has similar demographics and a similar incidence of EHR compared to our 
previous national cohort. Additionally, compared to national models, our study has a relatively 
small sample size, which may limit our ability to find an association between novel predictors and 
EHR in multivariate analysis. However, even in univariate analyses few novel predictors were 
associated with EHR. Another limitation is that we were only able to measure HRQOL, cognitive 
function, and physical function on a subset of the study population. Recipients agreeing to 
participate in this portion of the study may be systematically different than recipients that did not 
participate. In fact, among recipients who participated, HRQOL was generally high and cognitive 
and physical disabilities were uncommon.  
 
Using granular clinical data, our study has provided a deeper understanding of mechanisms of 
EHR. Readmission following KT is common and can involve complex clinical scenarios. Factors 
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beyond clinical characteristics may not be useful in predicting which recipients are at highest risk 
of readmission. The practice at our center appears to favor direct hospital admission to the 
transplant service. Evaluating recipients prior to readmission may help us determine which 
recipients actually require inpatient care and which can continue to be managed as outpatients.   
17	
	
Table 1.1: Study population characteristics, by early hospital readmission, n=400. 







Median age, IQR (years) 54, 42-65.5 57, 46-64 0.5 
Female, % 44.6 45.0 0.9 
African American, % 40.0 35.0 0.3 
BMI (kg/m2), % 
  Underweight (<18.5) 
  Normal (18.5-25) 
  Overweight (25-30) 












Diabetes, % 21.1 25.0 0.3 







Hepatitis C positive, % 5.7 10.8 0.07 
Donor type, % 
   Live  
   Deceased standard criteria 
   Deceased extended criteria 












Desensitization, % 24.6 31.7 0.1 

















Table 1.2: Route of readmission. 
 % 
Direct admission from home 40.8 
Emergency department 21.7 
Clinic 17.5 
Transfer from outside hospital 14.2 






Table 1.3: Recipient characteristics, by route of readmission. Direct admission is an admission 
directly from home without prior evaluation by a physician. Other routes included outpatient 
clinic, the emergency department, and outside facilities.  
 







Median age, IQR (years) 57, 45-65 56, 45-62 0.5 
Female, % 45.1 44.9 0.9 
African American, % 39.4 28.6 0.2 
Public insurance, % 60.6 51.0 0.3 
Median transplant length of stay, IQR 
(days) 
11, 8-20 10, 7-18 0.6 
Median readmission length of stay, 
IQR (days) 
5, 2-12 4, 3-7 0.3 
Median distance from transplant 
Center, (miles) 
36.9, 9.6-69.7 33.3, 16.6-129.3 0.3 





Table 1.4: Reason for readmission.  
 % 
Infection 24.2 
Gastrointestinal  14.2 
Fluid collection 14.0 
Hyperkalemia 9.2 
Rejection  8.3 
Volume Overload 5.8 
Cardiac 2.5 
Genitourinary 2.5 





Table 1.5: Health related quality of life, cognitive impairment, functional dependence, and 
physical disability, by early hospital readmission, by early hospital readmission. Health related 
quality of life (HRQOL) was measured on a Likert scale from “Poor” to “Excellent”, cognitive 
impairment was defined as a mini-mental status test score <79, functional dependence was 
defined as requiring assistance with one or more activity of daily living (ADL) or as requiring 
assistance with 1 or more instrumental activity of daily living (IADL), and physical disability was 
defined as a short battery of physical function (SBPP) score less than 8.  
 
 No Early  
Hospital Readmission 
Early Hospital  
Readmission 
p-value 
Health related quality of life, % 
   Excellent 
   Very Good 
   Good 
   Fair 














Cognitive Impairment, % 6.1 5.0 0.7 
Functional dependence ADLs, % 7.9 15.5 0.06 
Functional dependence IADLs, % 9.8 15.3 0.2 
Physical disability, % 1.1 1.7 0.6 




Table 1.6: Unadjusted relative risk of early hospital readmission following kidney transplantation, 
by each novel predictor. Each predictor was explored in a separate unadjusted model. 
 
 RR  p-value 
Fair or poor health related quality of life  0.550.781.11 0.2 
Cognitive impairment 0.430.861.75 0.7 
ADL functional dependence 1.021.562.40 0.04 
IADL functional dependence 0.881.372.14 0.2 
Physical disability 0.451.343.96 0.6 
Grip strength rating 0.980.991.01 0.4 
Public insurance 1.011.361.84 0.046 
Fixed income 0.670.931.28 0.7 
Married 0.690.941.28 0.7 
College education 0.831.151.58 0.4 
Employed 0.640.861.17 0.3 
Living with cohabitants 0.600.961.53 0.9 
IV drug use 0.110.663.87 0.6 
Mental health issues 0.851.171.62 0.3 
Legal issues 0.060.412.58 0.3 
Financial issues 0.771.121.63 0.6 




Table 1.7: Adjusted relative risk of early hospital readmission following kidney transplantation. 
Adjusted for recipient, donor, and transplant characteristics. 
 
  
 RR p-value 
Age (per year) 
    <40 
    40-70 









African American 0.600.921.40 0.7 
BMI (kg/m2),  
  Underweight (<18.5) 
  Normal (18.5-25) 
  Overweight (25-30) 











Females with diabetes 0.360.761.62 0.5 
Males with diabetes 0.540.931.59 0.8 
Dialysis vintage (per year) 0.930.981.03 0.4 
Hepatitis C positive 0.751.422.71 0.3 
Donor type 
   Live  
   Deceased standard criteria 
   Deceased extended criteria 











Desensitization 0.661.342.75 0.4 
Transplant length of stay 
    <5 days 







ADL functional dependence 0.751.302.27 0.3 
Public insurance 0.871.291.91 0.2 
Temporary housing for transplant 1.562.564.19 <0.001 
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Table 1.8: Socioeconomic factors, by early hospital readmission.  
 No Early Hospital  
Readmission 
 




Public insurance, %  45.7 56.7 0.04 
Fixed income, % 37.8 35.3 0.7 
Married, % 63.1 61.0 0.7 
Education level, % 
   Some high school 
   High school graduate 
   Some college 
   College graduate 














Employed, % 48.6 43.3 0.3 
Living with cohabitants, % 88.9 88.3 0.9 
IV drug use, % 1.4 0.8 0.6 
Mental health issues, % 25.4 30.0 0.3 
Legal issues, % 2.7 0.9 0.3 
Financial issues, % 16.8 19.2 0.6 




Figure 1.1: Percent of kidney transplant recipients experiencing early hospital readmission by day 
since discharge following transplantation. Three, 7-, and 9-day incidence of readmission 











Figure 1.3: Proportion of direct admissions from home by time of day. Each dot represents one 
readmission. Dots at the top of the figure (y=100) are patients readmitted directly from home. 
Dots at the bottom of the figure (y=0) are patients readmitted through a different route. The plot 





CHAPTER 2: SOCIAL DETERMINANTS OF HEALTH AND READMISSION 
 
SUMMARY: 
Early hospital readmission risk after kidney transplantation is high and, while associated with 
age, race, and comorbidity, difficult to predict. We hypothesized that social determinants of 
health, i.e. those above and beyond individual characteristics, may be associated with 
readmission. Medicare data was linked to county health rankings and census data to study 52,738 
adult Medicare-primary first-time kidney-only recipients from December 1999-October 2011. 
Modified Poisson regression was used to estimate the association between 30-day readmission 
and community risk, socioeconomic status, residential setting, and distance to transplant center, 
adjusting for patient-level factors. Community risk was associated with readmission, such that 
living in low-intermediate, high-intermediate, and highest risk communities increased the risk of 
readmission (aRR 1.041.071.11, aRR 1.021.071.11, aRR 1.041.101.16, respectively) compared to living in 
lowest risk communities. There was no statistically significant association between readmission 
and socioeconomic status or readmission and residential setting. The risk of readmission was 
inversely associated with distance (<10 miles: reference, 10-90 miles: aRR 0.940.970.99, 90-180 
miles: aRR 0.860.900.94, 180-240 miles: aRR 0.760.820.89, >240 miles: aRR 0.740.941.21). Factors 
above and beyond the individual, such as community risk and distance from the transplant center, 





In the United States, 31% of kidney transplant (KT) recipients experience early hospital 
readmission (EHR), or readmission within 30 days of discharge following initial KT 
hospitalization (1). Early hospital readmission is important not only because of its burden to the 
patient and the medical system, but also as an independent predictor of both graft and patient 
survival (2). Patient-level clinical characteristics associated with EHR include age, African 
American race, various comorbidities, extended criteria donor, lack of induction therapy, and 
increased length of stay. However, despite these patient-level associations, it remains difficult for 
providers to predict which patients will experience EHR. We have explored center-level factors, 
hoping these would help explain which patients are at risk for EHR; however, despite wide 
center-level variation in the incidence of readmission following KT, conventional center-level 
characteristics are not associated with readmission (1).  
 
A potential domain of risk contributing to EHR following KT is that of the environment in which 
the patient lives, rather than the attributes of the individual patient. Social determinants of health, 
such as access to care, socioeconomic status (SES), and home environment, influence health 
outcomes within the general population and even in transplant patients (20-28). For example, SES 
affects transplant access, such that high SES is associated with lower waitlist mortality or 
removal (aHR 0.840.860.89) and higher access to live donor transplantation (aHR 1.701.761.83) (27). 
Similarly, Schold et al. reported that among KT waitlist candidates, community risk, or the health 
behaviors of individuals living near transplant candidates and recipients, negatively impacts 
transplant access and outcomes. Candidates living in the highest risk communities have increased 
waitlist mortality (aHR 1.161.221.28), decreased access to living donor KT (aOR 0.850.900.94), and 
increased waitlist removal (aHR 1.221.361.51). Even when candidates living in the highest risk 




The transition from inpatient to outpatient care following KT is complex, and we hypothesized 
that social determinants of health may contribute to readmission. Understanding risk factors 
beyond clinical characteristics can help predict which KT recipients are at highest risk for 
readmission and can also guide development of tailored interventions to prevent readmission (29, 
30). The objective of this study was to evaluate the association between EHR and social 
determinants of health, specifically community risk, SES, residential setting, and distance from 
transplant center.  
 
METHODS 
Study Population and Ascertainment of Early Hospital Readmission 
We studied 52,738 adult first-time KT recipients from December 1, 1999 through October 31, 
2011 who had Medicare Part A and B as their primary insurance for at least 60 days before and 
60 days following the date of transplant. Early hospital readmission was captured using United 
States Renal Data System (USRDS) claims data. As specified in our previously published model 
of EHR following KT, EHR was defined as at least one hospital readmission to any acute care 
hospital within 30 days of discharge after initial KT hospitalization (1, 2). KT recipients that died 
prior to discharge were excluded (n= 618). KT recipients that died within the first 30 days after 
KT were excluded (n= 105), unless EHR occurred prior to death (n= 222). Donor, recipient, and 
transplant characteristics were obtained from Organ Procurement Transplantation Network data.  
 
Community Risk  
County health rankings data were used to generate a community risk score for each recipient’s 
county of residence based on ten health indicators (medial annual household income, prevalence 
of smoking, preventable hospitalizations, prevalence of physical activity, prevalence of adult 
obesity, prevalence of low birth weight, prevalence of poor physical health, prevalence of poor 
mental health, prevalence of poor/fair health, years of potential life lost), as previously described 
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(25, 26, 31). Potentially preventable hospitalizations are defined in this context as admissions to a 
hospital for acute illnesses or worsening chronic conditions that might have been avoided if a 
primary care provider in an outpatient setting had managed these conditions. For each of the ten 
indicators, the prevalence was categorized into quintiles and a cumulative score for each county 
was generated based on the sum of each quintile above the lowest risk category, or the first 
quintile, for each health indicator. For example, a county in the third quintile for each indicator 
would receive a risk score of 2 for each indicator, which results in a cumulative community risk 
score of 20. For regression modeling we also categorized community risk scores among recipients 
as lowest risk (score 0-10), low-intermediate risk (score 11-20), high-intermediate risk (score 21-
30), and highest risk (31-40), based on previously published models of community risk.  
 
Socioeconomic Status 
U.S. Census data was used to generate a SES index corresponding to each recipient’s zip code. 
The SES index was generated using the same method described by the Agency for Healthcare 
Research and Quality according to the formula 50 + (−0.07 × %crowded) + (0.08 × median 
property value) + (0.11 × median household income) + (−0.10 × %poverty) + (−0.11 × 
%education <12th grade) + (0.10 × %college) + (−0.08× %unemployed), with possible values 
standardized to range from 0 to 100 (32). A higher index value corresponds to higher SES and a 
lower index value corresponds to lower SES. For regression modeling we also categorized SES 
among recipients into quartiles (lowest SES quartile, low-intermediate SES quartile, high-
intermediate SES quartile, and highest SES quartile). 
 
Residential Setting 
Rural-urban commuting area (RUCA) codes were used to classify the residential setting 
corresponding to each recipient’s zip code. A RUCA code is assigned to each U.S. zip code based 
on population density and employment commuting data. Rural-urban commuting area 
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classification takes into account that certain low population density suburban zip codes may be 
associated with more densely populated urban areas. The RUCA codes range from 1.0 (most 
urban) to 10.6 (most rural). Three RUCA categories were defined a priori: metropolitan (RUCA 
1.0-3.9), micropolitan (RUCA 4.0-6.0), and rural (7.0-10.6). 
 
Distance from Transplant Center 
The distance between each recipient’s residence and their transplant center was calculated using 
the latitude and longitude of the geographic centroid of the patient's zip code and the latitude and 
longitude of the transplant center ascertained by Google maps search. Zip code locations were 
obtained from the ‘zip code’ package available through R, which contains a database of latitudes 
and longitudes for US zip codes from the CivicSpace database (August 2004) and augmented 
with data from federalgovernmentzipcodes.us (Jan 22, 2012). To account for the curve of the 
earth, the distance in miles was calculated using an arc-distance equation with the latitudes and 
longitudes expressed in radians (acos(cos(lat1) × cos(lat2) + sin(lat1) × sin(lat2) × cos(long1-




We compared differences in baseline characteristics across community risk categories (lowest 
risk, low-intermediate risk, high-intermediate risk, highest risk) using one-way analysis of 
variance for continuous variables and chi-squared tests for categorical variables. We estimated 
the relative risk of EHR associated with each social determinant of health (community risk score, 
SES, residential setting, and distance to center) using modified Poisson regression (13). We 
checked for collinearity between the social determinants of health and the mean variance inflation 
factor was 1.38 (range 1.14-1.38), suggesting little to no collinearity. A single model was used 
which included each of the four social determinants of health (community risk score, SES, 
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residential setting, and distance to center), as well as the following recipient, donor, and 
transplant characteristics based on our previously published model of EHR: age, sex, race, BMI, 
history of comorbidity (hypertension, cancer, hepatitis C positive, chronic obstructive pulmonary 
disease, diabetes, current smoker, congestive heart failure, and dialysis vintage), donor age, donor 
type (standard criteria, extended criteria, donor after cardiac death), human leukocyte antigen 
(HLA) mismatch, use of induction therapy, and length of stay for KT admission (1). 
Socioeconomic status index was categorized by quartile. Based on empirical exploration of the 
data, distance was categorized as <10 miles, 10-90 miles, 90-180 miles, 180-240 miles, and >240 
miles. A separate model, adjusted for recipient, donor, and transplant characteristics was used to 
estimate the relative risk of EHR associated with each component of the community risk score. 
Similarly a separate model, adjusted for recipient, donor, and transplant characteristics, was used 
to estimate the relative risk of EHR associated with each component of the SES index. 
Confidence intervals are reported as per the method of Louis and Zeger, as previously described 
(14, 15). All analyses were performed using STATA 14.0/MP for Linux (Stata Corp LP, College 
Station, TX, USA). 
 
RESULTS 
Study Population  
There were 52,738 adult first-time KT recipients with available zip code and county code 
information. In univariate analyses recipients living within the highest risk communities were 
more likely to be African American, obese, and have a higher burden of comorbidity 
(hypertension, CMV, COPD, smoking, and congestive heart failure). Recipients living within the 
highest risk communities were also more likely to have a low SES and live in a rural setting 






The mean community risk score was 15.3 (SD=9.0) (median 14, IQR 8-21). In multivariate 
analysis adjusted for recipient, donor, and transplant characteristics and adjusted for SES, 
residential setting, and distance from center there was an association between community risk and 
EHR. Living in a low-intermediate risk (aRR 1.041.071.11, p<0.001), high-intermediate risk 
(1.021.071.11, p=0.002), or highest risk community (1.041.101.16, p=0.001) was associated with an 
increased risk of EHR (Table 2.2).  
 
In multivariate analysis adjusted for recipient, donor, and transplant characteristics readmission 
was associated with several components of community risk. For every 10% increase in the county 
prevalence of smoking there was a 1.04-fold increase in the risk of readmission (aRR 1.011.041.07, 
p=0.004) (Table 2.3). For every 100 preventable hospitalizations per county there was a 1.25-fold 
increase in the risk of EHR for the recipient (aRR 1.111.251.33, p<0.001). For every 10% increase in 
the county prevalence of physical inactivity, there was a 1.07-fold increase in the risk of EHR 
(aRR 1.041.071.10, p<0.001). For every 10% increase in county prevalence of adult obesity, there 
was a 1.04-fold increase in the risk of EHR (aRR 1.011.041.07, p=0.02). For every 10% increase in 
the county prevalence of low birth weight there was a 1.09-fold increase in the risk of EHR (aRR 
1.011.091.19, p=0.03). However, there was no statistically significant association between median 
household income, poor physical health, poor mental health, poor/fair health, or potential life 
years lost and EHR. 
 
Socioeconomic Status 
The mean SES index was 58.6 (SD=7.6)(median 58.7, IQR 53.1 to 64.4). In multivariate analysis 
adjusted for recipient, donor, and transplant characteristics and adjusted for community risk, 
residential setting, and distance from center there was no statistically significant association 




In multivariate analysis adjusted for recipient, donor, and transplant characteristics EHR was 
associated with one component of the SES index. For every 1% increase in the proportion of zip 
code crowding there was a 0.69-fold decrease in the risk of EHR (aRR 0.480.690.99 p=0.048) (Table 
2.4). However, there was no statistically significant association between median annual 
household income, property value, prevalence of poverty, prevalence of adults with a college 
education or higher, prevalence of adults with lower than a high school education, or prevalence 
of unemployment and EHR. 
 
Residential Setting 
Of patients studied, 82.2% lived in an urban area, 9.7% lived in a micropolitan area, and 8.1% 
lived in a rural area. The mean distance to center for urban recipients was 15.1 miles, compared to 
72.2 miles for micropolitan and 84.4 miles for rural recipients. However, in multivariate analysis 
adjusted for recipient, donor, and transplant characteristics and adjusted for community risk, SES, 
and distance from center there was no statistically significant association between residential 
setting and EHR (Table 2.2).  
 
Distance to Transplant Center 
The mean distance from recipient home to transplant center was 44.9 miles (SD=52.4) (median 
21.9, IQR 8.0-64.4), 30.5% lived less than 10 miles from their transplant center, 52.6% between 
10 and 90 miles, 13.2% between 90 and 180 miles, 3.6% between 180 and 240 miles, and 0.3% 
greater than 240 miles from their transplant center. In multivariate analysis adjusted for recipient, 
donor, and transplant characteristics and adjusted for community risk, SES, and residential setting 
there was an inverse association between distance from center and risk of EHR. Compared to 
recipients living less than 10 miles away, there was a 0.97-fold decrease in the risk of readmission 
for those living 10 to 90 miles away (aRR 0.940.970.99, p=0.03), a 0.90-fold decrease in the risk for 
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recipients living 90 to 180 miles away (aRR 0.860.900.94, p<0.001), a 0.82-fold decrease in the risk 
for recipients living 180 to 240 miles away (aRR 0.760.820.89, p<0.001), and a 0.94-fold decrease in 
risk for recipients living greater than 240 miles away (aOR 0.740.941.21, p=0.6) (Table 2.2).  
 
DISCUSSION 
In this national registry study of 52,738 KT recipients, EHR was associated with certain social 
determinants of health. Increased community risk was associated with an increased risk of EHR, 
and was likely driven by the association between EHR and several components of community 
risk that capture health behaviors within a given county (preventable hospitalizations, prevalence 
of physical inactivity, prevalence of low birth weight, and prevalence of smoking). Early hospital 
readmission was not associated with SES or residential setting. Recipients that lived within ten 
miles of their transplant center had an increased risk of EHR compared to all other distance 
categories. However, the difference was smallest between those living less than 10 miles away 
and those living greater than 240 miles away, possibly because patients living greater than 240 
miles from the transplant center temporarily stay in close proximity to the center immediately 
following transplant discharge.  
 
Our study is the first to examine the association between community risk and EHR. Community 
risk has been shown to be associated with other post-transplant outcomes. Schold et al. found that 
KT recipients from the highest risk communities had a 1.50-fold increase in the risk of graft loss 
and a 1.45-fold increase in the risk of post-KT mortality (25, 26). Interestingly, we found an 
increased risk of EHR among recipients in all counties that were not lowest risk, compared to 
Schold’s finding related to mortality wherein only recipients in the highest risk communities were 




We found no association between SES index and EHR, which is consistent with previous work on 
readmission following KT. In a single center study of 753 KT recipients, Marhay et al. used the 
same SES index used in our study and found no association between SES and readmission (4). 
Interestingly, SES has been shown to be associated with other post-transplant outcomes. In 
particular, Axelrod et al. found an association between the SES index and post-KT mortality (27). 
Early hospital readmission, although associated with post-transplant survival, may be a 
mechanistically different outcome, which is independent of SES. Across other fields, the 
association between SES and readmission varies. In a systematic review of readmissions 
following hospitalization for community acquired pneumonia and heart failure, Cavillio-King et 
al. showed that readmission was associated with lower education, low income, and 
unemployment (34). In a study of 12,000 patients admitted to four large hospitals in 
Massachusetts, Weissman et al. showed that poor patients and unskilled laborers both had a 1.25-
fold increase in the odds of readmission (35). Conversely, in a study of 13,338 orthopedic 
patients, Hunter et al. showed that after adjusting for other patient-level characteristics, median 
household income, ascertained through census data, was not associated with readmission (aOR 
0.490.731.09, high income compared to low income) (36).  
 
We found no association between EHR and residential setting. Our findings are consistent with 
the largest longitudinal study of readmission and residential setting among Medicare 
beneficiaries. In a study 11,733 Medicare beneficiaries, Toth et al showed that after adjusting for 
patient-level characteristics rural residency was not associated with readmission (aOR 0.861.001.17 
for larger rural setting; aOR 0.971.201.49 for small rural setting; aOR 0.951.171.44 for isolated rural 
setting) (37).  
 
We found that distance to transplant center was associated with EHR in a stepwise fashion. 
Recipients living within ten miles of their transplant center were at highest risk and in general that 
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risk decreased as distance increased. Across other fields, the association between readmission and 
distance varies. Similar to our findings, in a study of 10,633 cases of athroplasty, Zmistowski et 
al. showed that the risk of readmission decreased with increasing distance from the hospital (aOR 
0.400.520.66 per mile) (38). In a study of 148 patients undergoing placement of a left ventricular 
assist device, Hernandez et al. found that distance was associated with a decrease in the risk of 
readmission (aOR 0.9950.9980.999 per mile) (39). Conversely, in a study of 23,779 patients 
undergoing major cancer surgery, Stitzenberg et al. found that compared to the closest quartile of 
distance, living in the second and fourth quartiles of distance increased the risk of readmission 
(second quartile: aIRR 1.27, fourth quartile: aIRR 1.14) (40).  
 
Our study had several notable limitations. Our study population is limited to Medicare-primary 
KT recipients, who may be systematically different from KT recipients with private insurance. 
However, over half of all KT recipients are insured through Medicare and eligibility is 
determined based on their renal failure rather than traditional eligibility based on disability or age. 
Another limitation is that we were unable to ascertain community risk, SES, and distance at the 
patient-level. Instead we had to use surrogate measures based on patient county and zip code. Our 
analysis may miss important variation within county or within zip code. Variation may be 
common within large counties or zip codes. However, our findings are largely consistent with 
existing literature, some of which used more granular measures.  
 
Social determinants of health, including health behaviors of the surrounding community and 
distance from transplant center, contribute significantly to EHR and must be considered to 
develop personalized post-KT care plans that aim at maximizing outcomes while minimizing 
complications and cost. By leveraging knowledge of a recipient’s social situation following KT, 
providers may be able to avoid EHR and its long-term effects.   
39	
	
Table 2.1: Study population characteristics, by community risk score, n=52,738. County health 
rankings were used to generate a community risk score for each recipient’s county of residence 
based on ten health indicators (median annual household income, prevalence of smoking, 
preventable hospitalizations, prevalence of physical activity, prevalence of adult obesity, 
prevalence of low birth weight, prevalence of poor physical health, prevalence of poor mental 





































Median age, IQR (years) 54, 42-64 53, 42-62 53, 42-62 52, 41-60 <0.001 
Female, % 38.6 38.9 39.7 39.0 0.3 











Recipient BMI (kg/m2), 
% 
  Underweight (<18.5) 
  Normal (18.5-25) 
  Overweight (25-30) 


























Hypertension, % 77.5 77.8 80.7 78.6 <0.001 
Cancer, % 2.4 1.9 2.2 1.9 0.03 
Hepatitis C positive, % 5.0 5.2 6.1 7.0 <0.001 
Chronic obstructive  










Diabetes, % 34.4 36.0 37.0 34.2 0.003 
Current smoker, % 4.0 3.8 5.4 6.2 <0.001 
Congestive heart failure 12.0 12.5 14.3 13.3 <0.001 
Median dialysis  
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Distance from  
transplant center, % 
   < 10 miles 
   10 to 90 miles 
   90 to 180 miles 
   180 to 240 miles 

































Table 2.2: Relative risk of early hospital readmission following kidney transplantation, by social 
determinants of heath. The relative risk of early hospital readmission for each social determinant 
of health (community risk, socioeconomic status, residential setting, and distance from transplant 
center) was estimated in a single multivariate model adjusted for recipient, donor, and transplant 
characteristics. 
 
 aRR p-value 
Community risk score  
   Lowest risk (0-10) 
   Low-Intermediate risk (11-20) 
   High-Intermediate risk (21-30) 











Socioeconomic index quartile 
   Lowest SES quartile  
   Low-Intermediate SES quartile  
   High-Intermediate SES quartile  












   Urban 
   Micropolitan 









Distance from transplant center, miles 
   <10  
   10-90 
   90-180 
   180-240 













Adjusted for age, sex, race, body mass index, diabetes, hypertension, chronic obstructive 
pulmonary disease, congestive heart failure, cancer, smoking, hepatitis C seropositivity, donor 




Table 2.3: Relative risk of early hospital readmission following kidney transplantation, by each 
component of the community risk score. Each component is at the county level and was explored 
in a separate model adjusted for recipient, donor, and transplant characteristics. 
 
 aRR p-value 
Median annual household income, per $10,000 0.900.991.00  0.1 
Prevalence of smoking, per 10% increase 1.031.061.09  <0.001 
Preventable hospitalizations, per 10 hospitalizations 1.021.021.03 <0.001 
Prevalence of physical inactivity, per 10% increase 1.041.071.10 <0.001 
Prevalence of adult obesity, per 10% increase 1.011.041.07 0.02 
Prevalence of low birth weight, per 10% increase 1.011.091.19 0.03 
Prevalence of poor physical health, per 10% increase 0.981.191.46 0.08 
Prevalence of poor mental health, per 10% increase 0.951.171.44 0.1 
Prevalence of poor/fair health, per 10% increase 0.960.991.02 0.4 
Years potential life lost, per 10 years 0.991.001.00 0.07 
Adjusted for age, sex, race, body mass index, diabetes, hypertension, chronic obstructive 
pulmonary disease, congestive heart failure, cancer, smoking, hepatitis C seropositivity, donor 
type, donor age, receipt of induction therapy, zero HLA mismatch, transplant length of stay. 
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Table 2.4: Relative risk of early hospital readmission following kidney transplantation, by each 
component of the socioeconomic status index. Each component is at the zip code level and was 
explored in a separate adjusted model. 
 
 aRR p-value 
Median annual household Income, per $10,000 0.990.991.00 0.7 
Prevalence of crowding, per 1% increase 0.480.690.99 0.048 
Prevalence of poverty, per 1% increase 0.991.001.00 0.7 
Mean property value, per $10,000 0.991.001.00 0.4 
Adults with college education or higher, per 1% increase 0.991.001.00 0.8 
Adults with high school education or lower, per 1% increase  0.990.991.00 0.3 
Prevalence of unemployment 0.991.001.00 0.4 
Adjusted for age, sex, race, body mass index, diabetes, hypertension, chronic obstructive 
pulmonary disease, congestive heart failure, cancer, smoking, hepatitis C seropositivity, donor 





CHAPTER 3: IMPACT OF READMISSION FOLLOWING KIDNEY TRANSPLANTATION 
 
SUMMARY: 
Following kidney transplantation, early readmission is independently associated with graft loss 
and mortality, but the mechanism of this association is poorly understood. A better understanding 
of the timeline of risk, i.e. during the readmission hospitalization versus time periods post-
readmission, is needed to provide additional insights. We used national registry data to study 
56,076 adult Medicare-primary first-time kidney transplant recipients from December 1999-
October 2011. Piecewise Cox proportional hazard models were used to estimate the association 
between graft loss, mortality, and readmission for two time periods: readmission hospitalization 
and post-readmission. During the readmission hospitalization, graft loss was substantially higher 
(deceased donor hazard ratio: 19.325.232.9, p<0.001; live donor: 18.136.774.2, p<0.001) and mortality 
was substantially higher (deceased donor: 13.918.123.4, p<0.001; live donor: 9.0018.241.3, p<0.001). 
Immediately following readmission discharge, graft loss (deceased donor: 2.192.442.73, p<0.001; 
live donor: 2.002.503.13, p<0.001) and mortality (deceased donor: 2.202.442.71, p<0.001; live donor: 
1.902.342.88, p<0.001) remained elevated, but much less so. In the years following readmission, the 
hazard of graft loss remained, but further decreased 19% per year for deceased donor recipients 
(time varying coefficient 0.780.810.85, p<0.001) and 14% per year for live donor recipients 
(0.790.860.93, p<0.001). The hazard of mortality remained, but further decreased 14% per year for 
deceased donor recipients (0.830.860.89, p<0.001) and 9% per year for live donor 
recipients(0.850.910.98, p<0.001). In conclusion, readmission is most strongly associated with graft 
loss and mortality during the readmission hospitalization, but also portends a lasting, albeit 




Over 30% of kidney transplant (KT) recipients experience early hospital readmission (EHR), or 
re-hospitalization within 30 days of discharge following KT (1). To appropriately manage these 
recipients, it is vital to understand the immediate and long-term ramifications of EHR. Early 
hospital readmission increases the risk of subsequent hospitalization within the first year 
following KT. In addition, EHR is associated with inferior graft and patient survival. Deceased 
donor KT recipients who experience EHR are 1.43 times more likely to lose their graft and 1.50 
times more likely to die compared to recipients who do not experience EHR. The same is true 
among live donor KT recipients who experience EHR; with a 1.54 fold increase in graft loss and 
a 1.45 fold increase in mortality (2).  
 
Existing estimates of the association between graft loss, mortality, and EHR, may be misleading. 
These numbers suggest that upon readmission to the hospital, a recipient’s risk for graft loss 
increases by approximately 50% and their risk remains elevated indefinitely after the readmission 
is over. In other words, the risk of graft loss and death for recipients who are acutely ill and 
readmitted to the hospital is considered the same as the risk for recipients who experienced EHR 
in the past, survived that readmission, and are currently months or years post-readmission. Prior 
work in transplantation, and other fields, assumes that the risk associated with EHR is constant 
over time without considering the possibility that it may vary with time (2, 41-49). In particular, 
the association between EHR and adverse transplant outcomes may be substantially different for 
KT recipients that are in the hospital experiencing EHR and those that have previously 
experienced EHR. Furthermore, it is unknown whether recipients who previously experienced 
EHR carry an increased risk of adverse outcomes for the remainder of their life or if that risk 
attenuates over time. Assuming a constant association may underestimate the risk attributable to 
the readmission hospitalization and it may give an inaccurate estimate of the durability of that 




The objective of this study was to quantify the association between EHR and survival during two 
distinct time periods: the EHR hospitalization and post-EHR. A second objective of the study was 




Study Population  
The study population included 56,076 adult first-time KT recipients from December 1, 1999 
through October 31, 2011 who had Medicare Part A and B as their primary insurance for at least 
60 days before and 60 days following the date of transplant. Recipient, donor, and transplant 
characteristics were obtained from Organ Procurement Transplantation Network data. This study 
was reviewed by the institutional review board at Johns Hopkins School of Medicine and 
determined to qualify for an exemption under 45 CFR 46.101(b) as study participants cannot be 
identified directly or through linked identifiers. 
 
Exposure and Outcome Ascertainment 
EHR hospitalization was captured using United States Renal Data System (USRDS) claims data. 
As specified in our previously published models of EHR following KT, EHR was defined as any 
hospitalization to an acute care facility within 30 days of discharge after initial KT hospitalization 
(1, 2). KT recipients who died prior to initial discharge following KT were excluded (n= 1,743). 
KT recipients who had graft loss prior to discharge, but did not die, were also excluded from the 
analysis (n=1,489) because readmission in a recipient with a functioning graft at the time of 





Association Between EHR and Survival 
Cox proportional hazard models were used to estimate the hazard of death-censored graft loss and 
mortality associated with EHR. Separate models were used for deceased donor kidney transplant 
(DDKT) and live donor kidney transplant (LDKT). Each model was adjusted for recipient, donor, 
and transplant characteristics based on the Scientific Registry of Transplant Recipients risk 
adjustment models (50). Models for DDKT were adjusted for age, sex, African American race, 
body mass index (BMI), pre-emptive transplant, cause of end stage renal disease (ESRD), peak 
panel reactive antibody, hepatitis C status, time on dialysis, human leukocyte antigen (HLA) 
mismatch, pulsatile perfusion, cold ischemic time, donor/recipient weight ratio, donor race, 
terminal creatinine, donor hypertension, donor diabetes, extended criteria donor, donation after 
cardiac death, regional/national sharing. Models for LDKT were adjusted for age sex, African 
American race, BMI, pre-emptive transplant, cause of ESRD, peak panel reactive antibody, 
hepatitis C status, time on dialysis, HLA mismatch, recipient/donor weight ratio, donor race. 
Recipients were censored at 5 years of follow-up, time of re-transplant, or administratively at 
end-of-study. We used a clustered sandwich estimator for standard errors to account for possible 
center-level correlation. The proportional hazard assumption for each model was confirmed 
visually using log-log plots and Schoenfeld residuals.  
  
We estimated the hazard of death-censored graft loss and mortality for two distinct time periods: 
from EHR admission date to EHR discharge or death/graft loss (EHR hospitalization) and from 
EHR discharge date to death/graft loss or censorship (post-EHR). To avoid immortal person-time 
bias among KT recipients with EHR (requiring patient and graft survival up to the point of 
readmission) we used a standard method of late entries in which the recipients with EHR only 
contributed to the exposed risk set starting at the time of admission for the EHR hospitalization. 
Based on exploratory data analysis and prior hypotheses, the attributable hazard during the EHR 
hospitalization was treated as constant and we used a time-varying coefficient to estimate 
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attributable hazard during the post-EHR time period. In other words, the estimate for “EHR 
hospitalization” represents the hazard averaged over the entire hospitalization while the “post-
EHR” hazard represents the hazard at the time of EHR discharge and that hazard can vary based 
on the amount of time since EHR discharge.  
  
Statistical Analysis 
Confidence intervals are reported as per the method of Louis and Zeger, as previously described 
(14, 15). All analyses were performed using STATA 14.0/MP for Linux (Stata Corp LP, College 
Station, TX, USA). 
 
RESULTS 
Early Hospital Readmission  
Of 56,076 KT recipients, 17,739 experienced EHR (31.6%) (Table 3.1). The median time from 
transplant discharge to EHR was 8 days (IQR 4-15). Among recipients who experienced EHR, 
the length of stay for the EHR hospitalization ranged from 1 to 217 days with a median length of 
stay of 4 days (IQR 2-7 days).  
 
Crude Death-censored Graft Loss and Mortality   
Crude death-censored graft loss within 30 days of transplant discharge was 1.5% for recipients 
who experienced EHR and 0.2% for recipients without EHR (p<0.001). Crude mortality within 
30 days of transplant discharge was 0.8% for recipients who experienced EHR and 0.2% for 
recipients without EHR (p<0.001). Crude death-censored graft loss within one year of transplant 
discharge was 7.2% for recipients who experienced EHR and 2.4% for recipients without EHR 
(p<0.001). Crude mortality within one year of transplant discharge was 7.3% for recipients who 




Association Between EHR and Survival During the EHR Hospitalization Time Period  
During the EHR hospitalization, 1.2% (n=218) of recipients lost their graft. Median time from 
EHR admission to death-censored graft loss was 4 days (IQR 1-14), with 48 recipients losing 
their graft on the same day as EHR admission. During the EHR hospitalization, 0.9% (n=158) of 
recipients died. Median time from EHR admission to death was 12 days (IQR 3-29), with 11 
recipients dying on the same day as EHR admission. In an adjusted model, during the EHR 
hospitalization, DDKT recipients who experienced EHR were 25.2-times more likely to lose their 
graft compared to recipients without EHR (aHR 19.325.232.9, p<0.001) (Table 3.2). LDKT 
recipients who experienced EHR were 36.7-times more likely to lose their graft compared to 
recipients without EHR (aHR 18.136.774.2, p<0.001). During the EHR hospitalization, DDKT 
recipients who experienced EHR were 18.1-times more likely to die compared to recipients 
without EHR (aHR 13.918.123.4, p<0.001). LDKT recipients who experienced EHR were 18.2-
times more likely to die compared to recipients without EHR (aHR 9.0018.241.3, p<0.001). 
 
Association Between EHR and Survival During the Post-EHR Time Period 
During the post-EHR time period, 33.6% (n=5845) of recipients lost their graft, with a median 
time from EHR discharge to death-censored graft loss of 687 days (IQR 238-1212) and 355 
recipients losing their graft within 30 days of EHR discharge. During the post-EHR time period, 
22.5% (n=3953) of recipients died, with a median time from EHR discharge to death of 766 days 
(IQR 277-1265) and 158 recipients dying within 30 days of EHR discharge. In an adjusted model, 
during the post-EHR time period, DDKT recipients who previously experienced EHR were 2.44-
times more likely to lose their graft compared to recipients without EHR (aHR 2.192.442.73, 
p<0.001) (Table 3.2). LDKT recipients who previously experienced EHR were 2.50-times more 
likely to lose their graft compared to recipients without EHR (aHR 2.002.503.13,p<0.001). During 
the post-EHR time period, DDKT recipients who previously experienced EHR were 2.44-times 
more likely to die compared to recipient without EHR (aHR 2.202.442.71, p<0.001). LDKT 
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recipients who previously experienced EHR were at a 2.34-times more likely to die compared to 
recipients without EHR (aHR 1.902.342.88, p<0.001). During the post-EHR time period, the hazard 
of graft loss for recipients who previously experienced EHR decreased linearly over time by 19% 
per year for DDKT recipients (time varying coefficient (tvc) 0.780.810.85, p<0.001) (Figure 3.1A) 
and 14% per year for LDKT recipients (tvc 0.790.860.93, p<0.001) (Figure 3.1B). During the post-
EHR time period, the hazard of death for recipients who previously experienced EHR decreased 
linearly over time by 14% per year for DDKT recipients (tvc 0.830.860.89, p<0.001) (Figure 3.2A) 
and by 9% per year for LDKT recipients (tvc 0.850.910.98, p=0.009) (Figure 3.2B). 
 
DISCUSSION 
In this national study of 56,076 first-time KT recipients, we found that the association between 
EHR and adverse transplant outcomes is dynamic. The majority of death-censored graft loss and 
mortality attributable to EHR occurred during the EHR hospitalization. During the EHR 
hospitalization, graft loss was 25.2-times higher for DDKT recipients and 36.7-times higher for 
LDKT recipients. Similarly, mortality was 18.1-times higher for DDKT recipients and 18.2-times 
higher for LDKT recipients. Immediately following readmission discharge, graft loss and 
mortality remained elevated, but much less so. Graft loss was 2.44-times higher for DDKT 
recipients and 2.50-times higher for LDKT recipients. Similarly, mortality was 2.44-times higher 
for DDKT recipients and 2.34-times higher for LDKT recipients. The hazard of death-censored 
graft loss and mortality continued to decrease with long-term post-EHR follow-up. 
 
Current understanding of the association between EHR and mortality averages the risk 
attributable to EHR over the entire follow-up period. This approach may underestimate the risk 
during readmission hospitalization and may over-estimate the risk post-readmission. In our 
previous work on EHR following KT, we found that EHR was associated with 1.50-times higher 
mortality over 5 years of follow-up (2). Our new approach demonstrates that the risk attributable 
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to EHR is highest during the EHR hospitalization and declines over time. Outside the field of 
transplantation, readmission is a well-understood risk factor for mortality following surgery. 
Following various surgical procedures, including pancreatectomy, coronary artery bypass 
grafting, orthopedic repairs, colectomy, esophagectomy, and lung cancer resection, EHR is 
associated with a 2.3 to 6.6-fold increase in the risk of mortality (2, 41, 42, 46-49, 51). 
Interestingly, studies with longer follow-up have a lower estimated risk ratio, indicating the effect 
may be a partial artifact of study design and follow-up time.  
 
Our study is not the first to use time-varying exposure methods to change the understanding of a 
biological process (52-55). Previous work by our group used similar methods to show that in 
pediatric KT recipients and liver transplant recipients the hazard of graft loss varies over time and 
is highest during late adolescence and early adulthood (52, 53). Beyond the field of 
transplantation, several studies have used these methods. Bolard et al. used piecewise Cox 
proportional hazard models to show that the hazard of mortality by cancer stage varied with time  
post diagnosis (54). Similarly, Platt et al. used extended Cox proportional hazard models with 
time-varying covariates to better characterize predictors of fetal and infant mortality over the 
timeline of gestation (55). Our study is novel in treating EHR as a time-varying risk factor for 
adverse post-KT outcomes and to our knowledge is the first study to use these methods in the 
context of studying readmission.  
 
Our findings may have practical implications for management of KT recipients experiencing 
EHR. EHR substantially increases the risk during the EHR hospitalization. Recipients 
experiencing EHR should be managed with caution. Following EHR discharge, the risk of graft 
loss and mortality is attenuated but does not disappear completely. Detailed discharge planning, 
frequent outpatient follow-up, and open communication between the recipient and transplant team 
may help mitigate the risk immediately post-EHR. Conversely, several years post-EHR, the 
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remaining risk is minimal and recipients that make it to this point are unlikely to require 
specialized care.  
 
Our study had several notable limitations. To ascertain readmission we had to limit our study 
population to with Medicare as their primary insurer. Medicare primary KT-recipients may be 
systematically different than KT recipients with alternative insurance providers. However, 
Medicare is the leading primary insurer for approximately half of all KT recipients, making our 
study population an important sub-set of the general KT population. In addition, since all 
individuals with end-stage renal disease (ESRD) requiring dialysis are Medicare eligible, 
regardless of age or disability, our inferences should be minimally affected. A further limitation 
of our study is that we cannot determine whether recipients that lost their graft during 
readmission were readmitted because they were already losing their graft or they lost their graft 
as a result of readmission. Similarly, death during readmission could represent failure to rescue or 
death due to the readmission itself. Even though we cannot directly delineate the casual pathway 
between EHR and adverse outcomes, our study is the first to isolate the EHR hospitalization time 
period as a source of substantial risk. 
 
In conclusion, EHR remains a frequent and noteworthy occurrence post-KT. Recipients 
experiencing EHR should be managed with great care, as they are more susceptible to adverse 




Table 3.1: Study population characteristics, by early hospital readmission, n=56,076.  
 No Early Hospital 
Readmissions 
n= 38,337 




Median age, IQR (years) 53, 41-62 55, 44-63 < 0.001 
Female (%) 38.9 39.3 0.3 
African American race (%) 30.7 35.9 < 0.001 
Recipient BMI, kg/m2 (%) 
  Underweight (<18.5) 
  Normal (18.5-25) 
  Overweight (25-30) 












Hepatitis C positive (%) 4.9 6.6 <0.001 
Cause of ESRD (%) 
   Congenital 
   Diabetes 
   Glomerulonephritis 
   Hypertension 














Median dialysis vintage, IQR (years) 3.3, 1.8-5.0 3.6, 2.0-5.4 <0.001 
Median peak PRA, IQR 1, 0-16 2, 0-19 <0.001 
Donor race 
   Caucasian 
   African American 










Donor recipient weight ratio  0.97, 0.77-1.2 0.95, 0.7-1.2 <0.001 
Donor hypertension (%) 19.6 23.7 <0.001 
Donor diabetes (%) 4.6 5.6 <0.001 





Live donor (%) 24.2 21.1 <0.001 
ECD donor (%) 13.5 17.6 <0.001 
DCD donor (%) 6.9 8.0 <0.001 
Pre-emptive kidney transplant (%) 2.6 2.6 0.9 
HLA mismatch (%) 
   0 
   1 
   2 
   3 
   4 
   5 


















Regional/national share (%) 43.5 41.6 <0.001 
Median cold ischemia time 15, 7.5-21.5 15.5, 8.5-22 <0.001 




Table 3.2: Hazard of death-censored graft loss and mortality during early hospital readmission 

























Living Donor Recipients2 
 
18.136.774.2 9.0018.241.3 2.002.503.13 
 
1.902.342.88 
All p-values < 0.001 
1 Models adjusted for age, sex, African American race, body mass index, pre-emptive transplant, 
cause of end stage renal disease, peak panel reactive antibody, hepatitis C status, time on dialysis, 
human leukocyte antigen mismatch, pulsatile perfusion, cold ischemic time, donor/recipient 
weight ratio, donor race, terminal creatinine, donor hypertension, donor diabetes, extended 
criteria donor, donation after cardiac death, regional/national sharing.  
2 Models adjusted for age sex, African American race, body mass index, pre-emptive transplant, 
cause of end stage renal disease, peak panel reactive antibody, hepatitis C status, time on dialysis, 




Figure 3.1: Hazard ratio of post-readmission death-censored graft loss over time, comparing 
readmitted to non-readmitted (reference) (A) deceased donor (DDKT) and (B) live donor (LDKT) 






Figure 3.2: Hazard ratio of post-readmission mortality over time, comparing readmitted to non-










Early hospital readmission is associated with increased morbidity, mortality, and cost. Following 
simultaneous pancreas-kidney transplantation, rates of readmission and risk factors for 
readmission are unknown. We used United States Renal Data System and Organ Procurement and 
Transplantation Network data to study 3,643 adult Medicare primary first-time simultaneous 
pancreas-kidney recipients from December 1, 1999 - October 31, 2011. Early hospital 
readmission was any hospitalization within 30 days of discharge. Modified Poisson regression 
was used to determine the association between readmission and patient-level factors. Empirical 
Bayes statistics were used to determine the variation attributable to center-level factors. The 
incidence of readmission was 55.5%. Each decade increase in age was associated with an 11% 
lower risk of readmission to age 40, beyond which there was no association. Donor African-
American race was associated with a 13% higher risk of readmission. Each day increase in length 
of stay was associated with a 2% higher risk of readmission until 14 days, beyond which each day 
increase was associated with a 1% reduction in the risk of readmission. Center-level factors were 
not associated with readmission. The high incidence of early hospital readmission following 
simultaneous pancreas-kidney transplant may reflect clinical complexity rather than poor quality 




Hospital readmission is associated with increased morbidity, mortality and cost among patients in 
the United States. Approximately 20% of all Medicare patients are readmitted to the hospital 
within 30 days of hospital discharge. Readmission results in potentially avoidable costs as high as 
$12 billion annually (56). Since passage of the Affordable Care Act, rates of readmission are 
increasingly used as a measure of hospital quality (57). In 2009 the Centers for Medicare and 
Medicaid (CMS) began publicly reporting hospital readmission rates for pneumonia, heart attack, 
and heart failure, and in fiscal year 2013 they began the Hospital Readmission Reduction 
Program (HRPR), which financially penalizes hospitals with excess Medicare readmissions. In 
the first year alone, the HRPR resulted in penalties totaling $280 million. The clinical and 
financial impact has led to significant effort toward preventing early hospital readmissions (EHR) 
(58). 
  
General surgical readmissions have been well characterized. EHR in surgical patients has been 
associated with length of stay, comorbidities, and surgical complications. Rates of EHR following 
general surgery are as high as 22%, varying by center and procedure (30, 59-66). However, the 
frequency and patterns of readmission among transplant patients might differ greatly from those 
of general surgical patients because of the increased complexity of immunosuppression regimens, 
rejection, infection, and other transplant-specific complications. Based on national data, we 
recently demonstrated that 31% of kidney transplant recipients are readmitted within 30 days of 
discharge. We also identified a number of factors associated with EHR after kidney 
transplantation, including older age, African American race, various comorbidities (obesity, 
hypertension, diabetes, heart disease, chronic obstructive pulmonary disease, hepatitis C positive, 
and time on dialysis ), expanded criteria donor, length of stay, lack of induction therapy, and 




Unlike our understanding of EHR among patients following kidney transplantation, little is 
known about EHR following simultaneous pancreas-kidney transplantation (SPK). SPK is an 
important treatment option for patients with diabetes and end stage renal disease, however it is 
substantially more complex than kidney transplantation alone (KTA). Technical failure rates 
following pancreas transplant are as high as 8%. Reasons for failure include graft thrombosis, 
graft pancreatitis, anastomotic leak, and infection (67, 68). SPK recipients require increased 
immunosuppression and are at risk for developing metabolic derangement and hyperglycemia as 
their pancreas allograft begins to function (69-74). Existing long-term sequelae of diabetes, like 
gastroparesis, neurogenic bladder, and autonomic neuropathy, can compound complications post-
transplant (75-77). Given the high risk of perioperative complications, SPK recipients, on 
average, remain in the hospital longer than their KTA counterparts and have a higher risk of 
perioperative mortality (68, 69, 76-78). We hypothesize that the high-risk perioperative period 
following SPK is associated with increased EHR. However, the national landscape of EHR 
following SPK has not been described and risk factors for EHR are largely unknown. Two single 
center studies, of 98 and 93 SPK recipients, both demonstrate a readmission rate of approximately 
74% within the first three months after transplant (78, 79). Although, these studies begin to 
quantify the burden of EHR following SPK they do not identify which patients are at risk for 
EHR. In addition, these studies are limited by a small sample size and poor generalizability of 
single center data. To better understand EHR in SPK, we used United States Renal Data System 
(USRDS) and Organ Procurement and Transplantation Network (OPTN) data to capture 
readmissions among Medicare beneficiaries undergoing SPK. The objectives of this study were to 
identify factors associated with EHR after SPK and to explore center-level heterogeneity in EHR 






MATERIALS AND METHODS 
Study Population and EHR Ascertainment 
The study population included 3,643 adult first-time SPK recipients from December 1, 1999 
through October 31, 2011 who had Medicare Part A and B as their primary insurance for at least 
60 days before and 60 days following the date of transplant. As specified in our previously 
published model of EHR following KTA, EHR was defined as at least one hospital readmission 
to any acute care hospital within 30 days of discharge after initial SPK hospitalization (1). Time 
to readmission is defined as the number of days from the date of SPK hospitalization discharge to 
the date of admission for the readmission hospitalization. SPK recipients that died prior to 
discharge were excluded (n= 101). SPK recipients that died within the first 30 days after SPK 
were excluded (n=72), unless EHR occurred prior to death (n=14). Donor, recipient, and 
transplant factors were obtained from national registry data. The reason for EHR was ascertained 
by diagnosis related group (DRG) code from USRDS claims data. Mortality information was 
augmented by linkage to the Social Security Death Master File and to CMS data. This study was 
reviewed by the institutional review board at Johns Hopkins School of Medicine and determined 
to qualify for an exemption under 45 CFR 46.101(b) as study participants cannot be identified 
directly or through linked identifiers. 
 
Potential Factors Associated with EHR 
The following recipient, donor, and transplant factors were explored for potential association with 
EHR: age, sex, race, BMI, history of comorbidity (hypertension, cancer, hepatitis C positive, 
chronic obstructive pulmonary disease, type 1 diabetes, current smoker, congestive heart failure, 
peripheral vascular disease, cerebrovascular disease, and dialysis vintage), donor age, donor 
gender, donor race, donor height, donor BMI, donor type (standard criteria, extended criteria, 
donor after cardiac death), donor cause of death, cold ischemia time, terminal creatinine, human 
leukocyte antigen (HLA) mismatch, use of induction therapy, delayed graft function, method of 
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exocrine drainage, length of stay for SPK admission, and year of transplant. These factors were 
chosen based on our previously published model of EHR following KTA, the SRTR risk models 
for SPK, and empirical exploration (1, 50). 
 
Center-level Factors Associated with EHR 
The following center-level factors were explored for potential association with EHR: total SPK 
volume, average length of stay, percent of SPK recipients who were African American, median 
time to transplant, and percent preemptive transplants. Each center-level factor was calculated 
from OPTN data. We also explored the association between readmission following SPK and 
readmission following KTA by determining the observed to expected readmission ratio using 
empirical Bayes estimation and correlating at the center-level. 
 
Statistical Analysis 
We estimated the relative risk of EHR by patient-level factors using modified Poisson regression 
(13). The functional form for each continuous variable was informed by previous studies and 
ultimately determined empirically. The final multivariate model was selected for parsimony by 
minimizing the Akaike Information Criteria (AIC). Center-level heterogeneity and associated 
factors were explored using a random intercept, hierarchical (multilevel) model adjusted for 
important patient-level factors as determined above. All analyses were performed using STATA 




Of the 3,643 SPK recipients studied, 2,021 (55.5%) experienced at least one readmission within 
30 days of discharge after initial SPK hospitalization (Table 4.1). Mean and median time to EHR 
62	
	
was 8.8 (SD 7.4) and 7 (IQR 3-13) days (Figure 1). Mean and median length of stay for the EHR 
hospitalization was 7.3 (SD 9.7) and 4 (IQR 2-9) days.  
 
Reason for EHR 
Overall, the five most frequent primary reasons for EHR were infection (23.1%) , kidney/urinary 
tract disorders (16.2%), alimentary tract disorders (15.6%), pancreatic/hepatobiliary disorders 
(11.1), and electrolyte/nutritional disorders (10.3) (Table 4.2). Of all readmissions, 82.6% 
required medical management, 16.4% required surgical or procedural management, and 
management was unknown for 1%. The median length of the readmission varied by management 
type. The median length of stay was longer for readmissions requiring surgical or procedural 
management (11 days, IQR 6-18) compared to medical management (4 days, IQR 2-7).  
 
Among patients with a readmission length of stay of 48 hours or less, or a short-stay readmission, 
the top five most frequent reasons for EHR were alimentary tract disorders (19.4%), 
electrolyte/nutritional disorders (19.4%), infection (16.4%), kidney/urinary tract disorders 
(15.8%), and pancreatic/hepatobiliary disorders (6.5%). Among short-stay readmissions, 96.9% 
required medical management, 2.1% required surgical or procedural management, and 
management was unknown for 1%.  
 
Recipient Factors Associated with EHR 
Recipient age was associated with EHR (Table 4.3). For every decade increase in age there was a 
11% lower risk of EHR for recipients up to age 40 (aRR 0.89 per decade, 95% CI: 0.82-0.97, 
p=0.005). For example, a 40-year-old recipient would have a 21% lower risk of EHR than an 18-
year-old recipient (aRR 0.77, 95% CI: 0.64-0.92, p=0.005). For recipients over age 40 there was 
no association between age and EHR (aRR 1.05 per decade, 95% CI: 0.97-1.15, p=0.2). There 
was no evidence of a statistically significant association between EHR and African American 
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recipient race, BMI, or history of peripheral vascular disease (Table 4.3). In preliminary models, 
there was no evidence of a statically significant association between EHR and recipient history of 
hypertension, cancer, hepatitis C, chronic obstructive pulmonary disease, type 1 diabetes, current 
smoker, congestive heart failure, cerebrovascular disease, dialysis vintage, or delayed graft 
function. These factors were excluded from the final model. 
 
Donor Factors Associated with EHR 
African American donor race and donor BMI were associated with EHR (Table 4.3). African 
American donor race was associated with a 13% higher risk of EHR (aRR 1.13 ,95% CI: 1.04-
1.23, p=0.005). Overweight SPK recipients had a 12% higher risk of EHR compared to normal 
weight SPK recipients (aRR 1.12, 95% CI: 1.04-1.22, p=0.004). There was no evidence of a 
statistically significant association between EHR and an underweight BMI or obesity. In 
preliminary models, there was no evidence of a statistically significant association between EHR 
and donor age, donor gender, donor height, donor cause of death, extended criteria donor, 
donation after cardiac death, or terminal creatinine >2.5mg/dL (Table 4.3). These factors were 
excluded from the final model. 
 
Transplant Factors Associated with EHR 
The only transplant factor associated with EHR was length of stay for the initial SPK 
hospitalization (Table 4.3). Across the study population, length of stay ranged from 2 to 435 days; 
however, 93% of recipients had a length of stay between 5 and 30 days. Each increasing day of 
hospitalization was associated with a 2% increase risk of EHR up until 14 days (aRR 1.02 per 
day, 95% CI: 1.01-1.04, p<0.001), such that a length of stay of 14 days was associated with a 
24% higher risk of EHR compared to a length of stay of 5 days (aRR 1.24, 95% CI: 1.13-1.37, 
p<0.001). After 14 days, each increasing day of hospitalization was associated with a 1% 
decreased risk of EHR (aRR 0.99 per day, 95% CI: 0.98-0.99, p<0.001), such that a length of 
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stay of 30 days was associated with a 14% lower risk of EHR compared to a length of stay of 14 
days (aRR 0.86, 95%CI: 0.80-0.92, p<0.001), and no difference in risk of EHR compared to a 
length of stay of 5 days (aRR 1.07, 95% CI: 0.98-1.17, p=0.2). There was no evidence of a 
statically significant association between EHR and use of induction therapy (Table 4.3). In 
preliminary models, there was no evidence of a statistically significant association between EHR 
and cold ischemia time, HLA mismatch, method of exocrine drainage, or year of transplant. 
These factors were excluded from the final model. 
 
Center-level Heterogeneity 
The unadjusted rate of EHR by center ranged from 0% to 100%. After adjusting for patient-level 
factors (as delineated above), the ratio of observed to expected EHR varied by center from 0 to 
1.88 (mean 1.00, SD 0.26, median 1.00, IQR 0.87-1.13) (Figure 4.1). No center-level factors 
(total SPK volume, average length of stay, percent of African American SPK recipients, median 
time to transplant, or percent preemptive transplants) were associated with EHR after adjustment 
for patient-level factors (Table 4.4). Including transplant center in a multilevel model improved 
the fit and a likelihood ratio test yielded a p-value < 0.001. However, the interclass correlation 
coefficient was 0.014 (SD 0.006), meaning only 1.4% of the variation was at the center-level. 
After adjustment for patient-level risk factors, only one center had a statistically significantly 
different incidence of EHR than the national average (Figure 4.2). Almost no correlation was 
found between the observed to expected ratio of readmission for SPK and KTA within transplant 
centers (correlation coefficient 0.1).  
 
DISCUSSION 
In this national database study of readmission after SPK, 55.5% of first-time Medicare-primary 
adult SPK recipients were readmitted within 30 days of discharge following transplantation. The 
most common reason for readmission was infection. Only 16.4% of EHR was managed by 
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surgical or procedural interventions. We identified several patient-level risk factors associated 
with EHR. Readmission was more likely to occur if recipients were younger, donor race was 
African American, or the donor was overweight. Length of stay following transplantation was 
associated with an increased risk of readmission to a threshold of 14 days, after which point the 
increased length of stay was protective against EHR. Center-level factors were not associated 
with EHR. In fact, center-level characteristics had almost no effect on the variation in EHR and 
the incidence of EHR was nearly constant across transplant centers.  
 
Our findings provide a point of comparison between post-SPK and post-KTA readmissions. 
Overall, readmission is more prevalent following SPK (single center studies). In our previous 
study of 32,961 Medicare primary adult first-time KTA recipients, the incidence of EHR was 
31% (1). The higher incidence of EHR following SPK is likely given that SPK is a longer, more 
technically challenging operation than KTA. In addition, SPK recipients are at high risk for 
rejection, infection, dehydration, and metabolic derangements (67, 68, 70, 71, 76, 78-80). 
Perioperative complications following SPK may necessitate readmission.  
 
In our study, the most common reason for EHR was infection, accounting for 23.1% of 
readmissions. In our previous study of KTA, the most common reason for EHR was 
kidney/urinary tract disorders, accounting for 36% of readmissions, while infection only 
accounted for 12% of all post-KTA readmissions (1). For immunosuppressed, diabetic patients, it 
may be safer and ultimately beneficial to treat infections in the hospital, under direct monitoring. 
Collectively, kidney/urinary tract disorders and pancreatic/hepatobiliary disorders accounted for 
an additional 27.3% of post-SPK EHR. These readmissions are assumed to be secondary to 
complications with the respective allograft. Readmission in this setting may mitigate the 
development of more serious and costly complications later in the post-transplant course. In our 
study, 16.4% of all readmissions were managed by surgical or procedural interventions. Although 
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this is a relatively small proportion of total EHR, these readmissions may represent further 
examples of necessary and beneficial hospitalizations.  
 
Among all readmissions, 26% were short-stays, meaning the readmission hospitalization lasted 
48 hours or less. For short-stay readmissions, there is no point of comparison in the KTA 
literature. We would expect that short-stay readmissions be of lower acuity than prolonged 
readmissions. In our study, the most common reason for short-stay EHR was alimentary tract 
disorder or electrolyte/nutritional disorder, each accounting for 19.6% of readmissions. As 
classified by DRG code, alimentary tract disorder may mean a trivial condition such as nausea or 
a more serious complication like gastrointestinal bleeding. Likewise, electrolyte disorder can 
range from minor hyperkalemia requiring intravenous hydration to diabetic ketoacidosis causing 
coma. The severity of illness may not be evident at the time of initial evaluation. In clinical 
practice, recipients presenting with these symptoms may benefit from an intermediate level of 
observation before the decision is made to readmit. Intermediate monitoring may help tease out 
which recipients will improve with minimal intervention and which require further 
hospitalization.  
 
Following SPK, each decade increase in recipient age, to a threshold of 40 years, was associated 
with an 11% lower risk of readmission. This is in contrast to our published findings in KTA. 
Following KTA, for recipients under age 40, each decade increase in age was associated with a 
6% higher risk of readmission. One potential explanation for this discrepancy is that young 
diabetic patients may be less compliant with post-transplant care, as well as general management 
of their diabetes. Adherence to medication regimens and maintenance of glycemic control is 
particularly poor among adolescents and young adults with type 1 diabetes (81-86). Poor post-





Our study demonstrates that African American donor race is associated with an increased risk of 
readmission. This finding is consistent with inclusion of African American donor race in the 
pancreas donor risk index (PDRI). In creation of the PDRI, Axelrod et al. demonstrated that 
African American donor race is associated with a 27% increased risk of graft failure (87). Our 
study also demonstrates that recipient race is not associated with readmission. This finding is in 
contrast to the association between African American recipient race and inferior graft survival 
(88, 89).  
 
Each day increase in length of stay was associated with a 2% higher risk of readmission until 14 
days, beyond which each day increase was associated with a 1% reduction in the risk of 
readmission. The mechanism of this association is difficult to ascertain and likely complex. 
Prolonged length of stay can be due to medical complications, for example, delayed graft 
function, surgical site infection, or graft pancreatitis. Prolonged length of stay can also be 
secondary to non-medical factors, for example, poor understanding of new medication regimens, 
increased distance from the hospital, lack of family support at home, or even day of the week. In 
our study, a short length of stay was likely associated with a low risk of readmission because 
recipients discharged early tend to be low-risk themselves. These recipients are less likely to 
require readmission. On the other end of the spectrum, recipients with extremely prolonged 
hospitalization may not require readmission because their care has been optimized prior to 
discharge.  
 
Certain factors associated with post-KTA EHR were not associated with post-SPK EHR. Donor 
type (deceased, living, ECD, DCD) is associated with EHR following KTA. All SPK transplants 
are performed using deceased donor organs and only a very small percentage of donors are 
classified as ECD or DCD (0.3% and 2.3%, respectively), making this factor less likely to 
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contribute to organ quality and subsequent readmission. At the center-level, there was no 
correlation between readmission for SPK and readmission for KTA, suggesting that 
mechanistically these two types of readmissions are unique and independent of center-level 
practices. 
 
Our study has several notable limitations. To ascertain EHR we had to limit our study population 
to SPK recipients with Medicare as their primary insurance. Inclusion of only Medicare primary 
patients could differentially affect younger and older recipients and limit generalizability. 
However, since all individuals with end stage renal disease requiring dialysis are eligible for 
Medicare, we believe this will minimally affect our results. In fact, the median and interquartile 
range for age of SPK recipients in our study and among all SPK recipients captured by SRTR was 
identical (median 40, IQR 34-46). Factors explored in our analysis were limited to those currently 
collected through the Scientific Registry of Transplant Recipients. As such, we were unable to 
ascertain certain factors that may be important to post-SPK outcomes, for example mode of 
dialysis, blood transfusions, and post-surgical complications. Furthermore, in using national 
registry data we are unable to ascertain more granular factors, like socioeconomic status, which 
may confound some of our findings. Due to the relatively low national volume of SPK compared 
to KTA, we may be underpowered to detect an association between center-level factors and EHR.  
 
In conclusion, readmission of SPK recipients occurs with high frequency and though there is 
variation in the rate of EHR by transplant center, almost all of that variation is explained by 
differences in patient characteristics rather than differences in center-level practice. Younger SPK 
recipients are at higher risk for readmission and may benefit from better transitions of care and 
more frequent outpatient monitoring. The most common reasons for readmission were infection, 
kidney/urinary tract disorder, and pancreatic/hepatobiliary disorder. Readmission to treat 
infection or allograft complications may ultimately prevent the development of more serious post-
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transplant complications. Given the technical complexity of SPK and the high risk of diabetic 
complications among recipients, readmission may reflect clinical necessity rather than poor 









 No EHR, n= 1,622 EHR, n=2,021 p-value 
Mean Age, SD (years) 40.4, 8.0 39.9, 8.4 0.03 
Female, % 34.7 36.6 0.2 
African American race, % 18.4 22.4 0.004 
Recipient BMI (kg/m2), % 
  Underweight (<18.5) 
  Normal (18.5-25) 
  Overweight (25-30) 












Hypertension, % 80.5 79.7 0.5 
Cancer, % 0.3 0.4 0.7 
Hepatitis C Positive, % 3.9 3.6 0.6 







Type 1 Diabetes, % 49.7 48.7 0.5 
Current Smoker, % 5.9 6.6 0.4 
Congestive Heart Failure 12.4 12.5 0.8 
Cerebrovascular Disease 2.7 3.6 0.1 
Peripheral Vascular Disease 9.5 10.7 0.2 
Mean Dialysis Vintage, SD (years) 2.6, 1.9 2.6, 2.0 0.9 
Mean Donor Age, SD (years) 25.7, 9.9 26.0, 10.1 0.5 
Female Donor, % 31.3 30.8 0.7 
Donor Race, % 
  Caucasian 
  African American 










Donor BMI (kg/m2), % 
  Underweight (<18.5) 
  Normal (18.5-25) 
  Overweight (25-30) 












Donor Type, % 
   Standard Criteria 
   Extended Criteria 










Donor Cause of Death, % 
   Anoxia 
   Cerebrovascular Accident 
   Head Trauma 












Terminal creatinine >2.5 mg/dL, % 0.56 1.24 0.03 
Mean Length of Stay, SD (days) 14.1, 18.2 12.8, 9.9 0.02 
Zero HLA Mismatch 2.3 1.8 0.3 
Mean Cold Ischemia Time, SD (hours) 12.3, 6.2 12.2, 5.8 0.9 
Received Induction Therapy, % 78.8 80.6 0.2 
Delayed Graft Function, % 10.3 11.7 0.2 
Exocrine Drainage 
   Enteric 
   Bladder 












Table 4.2: Reason for early hospital readmission after simultaneous pancreas kidney 
transplantation, n=2,021. 
 
 SPK Recipients 
Experiencing  
EHR, n (%) 
Required 





Management, n (%) 
Infection 466 (23.1) 389 (83.5) 77 (16.5) 
Kidney/Urinary Tract Disorder 328 (16.2) 294 (89.7) 34 (10.4) 
Alimentary Tract Disorder 316 (15.6) 289 (91.5) 27 (8.5) 
Pancreatic/Hepatobiliary 
Disorder 
 226(11.1) 150 (66.4) 76 (33.6) 
Electrolyte/Nutritional Disorder 209 (10.3) 209 (100) 0 (0) 
Hematologic /Immunologic 
Disorder 
 91(4.5) 89 (97.8) 2 (2.2) 
Neurologic Disorder 86 (4.3) 86 (100) 0 (0) 
Unspecified Operative 
Procedure 
 59 (2.9) 0 (0) 59 (100) 
Rehabilitation  47 (2.3) 47 (100) 0 (0) 
Unknown Diagnosis 47 (2.3) - -  
Cardiac 41 (2.0) 37 (90.2) 4 (9.3) 
Other 
 
    Diagnosis unrelated to SPK 
    Vascular Disorder 
    Respiratory Disorder 
    Wound/Skin Breakdown 
    Diabetes/Endocrine 
          Disorder 
    Scheduled Follow-up 
    Musculoskeletal/Connective 
          Tissue Disorder 
    Drug Complications 













































Table 4.3: Relative risk of early hospital readmission after simultaneous pancreas-kidney 
transplantation, n=3,643.  
 
Factors Adjusted Relative Risk 
(95% CI) 
p-value 
Age (per decade) 
  18 to 40 years 
  Greater than 40 years 
 
0.88 (0.82, 0.97) 




Recipient African American Race 1.07 (0.98, 1.16) 0.1 
Recipient BMI (kg/m2) 
  Underweight (<18.5) 
  Normal (18.5-25) 
  Overweight (25-30) 
  Obese (>30) 
 
1.09 (0.94, 1,28) 
REF 
0.96 (0.87, 1.06) 






Peripheral Vascular Disease 1.10 (0.99, 1.23) 0.07 
Donor African American Race 1.13 (1.04, 1.23) 0.005 
Donor Asian Race 1.06 (0.97, 1.16) 0.2 
Donor BMI (kg/m2), % 
  Underweight (<18.5) 
  Normal (18.5-25) 
  Overweight (25-30) 
  Obese (>30) 
 
0.91 (0.78, 1.06) 
REF 
1.12 (1.04, 1.22) 






Lack of Induction 1.06 (0.98, 1.16) 0.2 
Length of stay (per day) 
  First 14 days 
  Greater than 14 days 
 
1.02 (1.01, 1.04) 







Table 4.4: Relative risk of early hospital readmission after simultaneous pancreas-kidney 
transplantation by center-level factors, n=3,643. 
 




   1-11 
   12-27 
   29-122 
 
REF 
1.18 (0.85, 1.63) 





Average length of stay (days) 
   4.8- 11.1 
   11.1- 14.6 
   14.7- 47.7 
 
REF 






Percent African American recipients 
   0- 7.7% 
   8.1- 21.4% 









Median time to transplant (years) 
   0.1- 0.7 
   0.7- 1.3 
   1.3- 3.7 
 
REF 
1.21 (0.97, 1.49) 





Percent Preemptive Transplant 
   0- 4.5% 
   4.6- 13.3% 
   13.8- 66.7% 
 
REF 
0.94 (0.75, 1.19) 








Figure 4.1: Ratio of observed to expected probability of early hospital readmission after 
simultaneous pancreas-kidney transplantation for each transplant center. The observed probability 
of EHR was calculated for each center. Based on each center’s case mix an expected probability 
of EHR was derived from the final model. Each dot represents the ratio of observed to expected 
probability of EHR for a given transplant center. A center that readmits exactly as many patients 
as expected falls on the reference line. Those that admit less than expected fall below the 






Figure 4.2: Relative risk of early hospital readmission after simultaneous pancreas-kidney 
transplantation by transplant center compared to national average. Each dot represents the relative 
risk of EHR for each transplant center in the United States, with 95% confidence interval. The 
confidence interval for all but one of the transplant centers overlaps the reference line, which 









We recently showed that 54% of simultaneous pancreas-kidney recipients experience early 
hospital readmission. To guide clinical management of these recipients, it is vital to understand 
whether early hospital readmission is associated with post-transplant outcomes, specifically late 
hospital readmission, death-censored graft loss, and mortality. We used United States Renal Data 
System data to study 3,054 adult Medicare primary first-time simultaneous pancreas-kidney 
recipients from December 1999-October 2011. Early hospital readmission was any 
hospitalization within 30 days of transplant discharge. Late hospital readmission was any 
hospitalization occurring between 30 days and 1 year after transplant discharge. Recipients 
experiencing early hospital readmission were at a higher risk of experiencing late hospital 
readmission (aRR 1.351.571.98, p<0.001). During readmission, recipients were at a higher risk of 
pancreas graft loss (aHR 7.8014.225.8, p<0.001), a higher risk of kidney graft loss (aHR 5.3418.463.2, 
p<0.001) and a higher risk of mortality (aHR 2.088.534.8, p=0.003). Immediately following 
readmission, the risk of graft loss and mortality dropped substantially, but remained elevated for 
pancreas graft loss (aHR 1.171.451.80, p=0.001) and kidney graft loss (aHR 1.171.461.81, p=0.001). 
Post-readmission there was no difference in the hazard of mortality comparing recipients that 
previously experienced readmission to recipients without readmission (0.991.251.57, p=0.055). 
Readmission following simultaneous pancreas-kidney transplantation substantially increases the 




Based on national registry data, we recently demonstrated that 54% of simultaneous pancreas-
kidney transplantation (SPK) recipients are readmitted within 30 days of discharge following 
initial SPK hospitalization. Clinical characteristics associated with early hospital readmission 
(EHR) were limited to younger recipient age, African American donor, and increased length of 
stay (12). Our ability to predict which SPK recipients will experience EHR remains limited, 
however understanding the clinical implications of readmission can guide management of these 
individuals during the EHR hospitalization and post-EHR. 
 
In other populations, readmission is associated with clinical outcomes (41, 42, 44, 46-49, 51, 90-
92). Among community dwelling older adults, EHR is associated with a 3-fold increase in one-
year mortality (44). Similarly, adults with advanced liver disease who are readmitted within 30 
days of hospitalization have a 2.6-fold increase in 90-mortality (90). Readmission is also 
associated with increased mortality following cancer resection, abdominal aortic aneurysm repair, 
and percutaneous coronary interventions (41, 42, 46-48, 91, 92). In the field of transplantation, 
EHR is a strong predictor of outcomes following kidney transplantation alone (KTA). Previous 
work from our group, using national registry data, found that EHR is associated with increased 
hospitalization within the first year following KTA. In addition, EHR following deceased donor 
KTA is associated with a 1.43-fold increase in the risk of graft loss and a 1.50-fold increase in the 
risk of mortality (2).  
 
The objective of this study was to quantify the association between EHR following SPK and 
survival during two distinct time periods: the EHR hospitalization and post-EHR. A second 
objective of this study was to quantify the association between EHR and subsequent 





Study Population  
The study population included 3,054 adult first-time SPK recipients from December 1, 1999 
through October 31, 2011 who had Medicare Part A and B as their primary insurance for at least 
60 days before and 60 days following the date of transplant. Donor, recipient, and transplant 
characteristics were obtained from Organ Procurement Transplantation Network data. This study 
was reviewed by the institutional review board at Johns Hopkins School of Medicine and 
determined to qualify for an exemption under 45 CFR 46.101(b) as study participants cannot be 
identified directly or through linked identifiers. 
 
Exposure and Outcome Ascertainment 
EHR was captured using United States Renal Data System (USRDS) claims data. As specified in 
our previously published models of EHR following SPK, EHR was defined as any hospitalization 
to an acute care facility within 30 days of discharge after initial SPK hospitalization (12). Late 
hospital readmission (LHR) was any hospitalization occurring between 30 days and 1 year after 
initial transplant discharge. SPK recipients that died prior to discharge were excluded (n=136). 
SPK recipients that had either pancreas or kidney graft loss prior to discharge, but did not die, 
were also excluded from the analysis (n=203) because readmission in a recipient with a 
functioning graft at the time of discharge is mechanistically different than readmission of a 
recipient that has already lost their graft.  
 
Association between EHR and LHR 
The association between EHR and LHR was estimated using modified Poisson regression, as 
previously described (13). The model was adjusted for recipient, donor, and transplant 
characteristics (recipient age, African American donor, and length of stay) known to be 
associated with EHR, based on our previously published national model (12).  
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Association Between EHR and Survival 
Cox proportional hazard models were used to estimate the hazard of death-censored graft loss and 
mortality associated with EHR. Separate models were used to estimate pancreas graft loss and 
kidney graft loss. Since the Scientific Registry of Transplant Recipients (SRTR) does not 
currently have a risk adjustment model for pancreas graft loss, our model for pancreas graft loss 
was adjusted for recipient, donor, and transplant characteristics (recipient age, recipient BMI, 
total end stage renal disease time, donor age, donor sex, African American donor, Asian donor, 
donor BMI, donor height, donor cause of death, DCD, terminal creatinine >2.5mg/dL, and cold 
ischemia time) based on the SRTR risk adjustment model for SPK recipient survival (50). Our 
model for recipient mortality was adjusted for these same characteristics. Our model for kidney 
graft loss was adjusted for recipient, donor, transplant characteristics (donor age, HLA mismatch, 
time on dialysis) based on the SRTR risk adjustment model for kidney graft loss following SPK 
(50). Recipients were censored at 5 years of follow-up, time of re-transplant, or administratively. 
We used a clustered sandwich estimator for standard errors to account for possible center-level 
correlation. The proportional hazard assumption for each model was confirmed visually using 
log-log plots and Schoenfeld residuals.  
  
The hazard of death-censored graft loss and mortality was estimated for two distinct time periods: 
from EHR admission date to EHR discharge or death/graft loss (EHR hospitalization) and from 
EHR discharge date to death/graft loss or censorship (post-EHR). To avoid immortal person-time 
bias among SPK recipients with EHR (requiring patient and graft survival up to the point of 
readmission) we used a standard method of late entries in which the recipients with EHR only 
contributed to the exposed risk set starting at the time of admission for the EHR hospitalization. 
Based on exploratory data analysis and prior hypotheses, the attributable hazard during the EHR 
hospitalization and post-EHR were treated as constant. In other words, the estimate for “EHR 
hospitalization” represents the hazard averaged over the entire hospitalization while the “post-
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EHR” hazard represents the hazard averaged over the amount of time since EHR discharge.  
  
Statistical Analysis 
Confidence intervals are reported as per the method of Louis and Zeger, as previously described 
(14, 15). All analyses were performed using STATA 14.0/MP for Linux (Stata Corp LP, College 
Station, TX, USA). 
 
RESULTS 
Early Hospital Readmission 
Of 3,053 SPK recipients, 1,701 experience EHR (55.7%) (Table 5.1). The median time from 
transplant discharge to EHR admission was 7 days (IQR 3-13. Among recipients who 
experienced EHR, the length of stay for the EHR hospitalization ranged from 0 to 152 days with a 
median length of stay of 4 days (IQR 2-8).  
 
Late Hospital Readmission  
Among all recipients, 9.8% experienced at least one LHR. Only 1.1% of recipients experienced 
greater than one LHR. In a multivariate model adjusted for recipient, donor, and transplant 
characteristics, EHR was associated with a 1.57-fold increase in the risk of LHR (aRR1.251.571.98, 
p<0.001).  
 
Crude Death-censored Graft Loss and Mortality 
Crude death-censored pancreas graft loss within 30 days of transplant discharge was 1.6% for 
recipients who experienced EHR and 0.5% for recipients without EHR (p=0.001). Crude death-
censored kidney graft loss within 30 days of transplant discharge was 0.3% for recipients who 
experienced EHR and 0.2% for recipients without EHR (p<0.6). Crude mortality within 30 days 
of transplant discharge was 0.4% for recipients who experienced EHR and 0.4% for recipients 
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without EHR (p=0.8). Crude one-year death-censored pancreas graft loss was 5.1% for recipients 
who experienced EHR and 2.6% for recipients without EHR (p<0.001). Crude one-year death-
censored kidney graft loss was 3.2% for recipients who experienced EHR and 1.6% for recipients 
without EHR (p<0.002). Crude one-year mortality was 2.9% for recipients who experienced EHR 
and 1.9% for recipients without EHR (p=0.09).  
 
Association Between EHR and Survival During the EHR Hospitalization Time Period 
During the EHR hospitalization, 1.8% (n=30) of recipients lost their pancreas graft. The median 
time to death-censored pancreas graft loss was 2 days (IQR 1-7), with 6 recipients losing their 
graft on the same day as EHR admission. During the EHR hospitalization, 0.6% (n=10) of 
recipients lost their kidney graft. The median time to death-censored kidney graft loss was 19 
days (IQR 6-44 days). No recipients lost their kidney graft on the same day as EHR admission. 
During the EHR hospitalization, 0.5% (n=8) of recipients died. The median time to death was 30 
days (IQR 17-68 days), with no recipients dying on the same day as EHR admission. In an 
adjusted model, during the EHR hospitalization, recipients who experienced EHR were 14.2- 
times more likely to lose their pancreas graft (aHR 7.8014.225.8,p<0.001) and 18.4-times more 
likely to lose their kidney graft compared to recipients without EHR (aHR 5.3418.463.2, p<0.001) 
(Table 5.2). During the EHR hospitalization, recipients who experienced EHR were 8.5-times 
more likely to die compared to recipients without EHR (aHR 2.088.534.8,p<0.003).  
 
Association Between EHR and Survival During the Post-EHR Time Period 
During the post-EHR time period 12.0% (n=196) of recipients who previously experienced EHR 
lost their pancreas graft. The median time to death-censored pancreas graft loss was 724 days 
(IQR 234-1185 days), with 26 recipients losing their pancreas graft within 30 days of post-EHR 
discharge. During the post-EHR time period 14.4% (n=214) recipients who previously 
experienced EHR lost their kidney graft. The median time to death-censored kidney graft loss of 
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791 days (IQR 462-1243), with 5 recipients losing their kidney graft within 30 days of post-EHR 
discharge. During the post-EHR time period, 8.9% (n=151) of recipients who previously 
experienced EHR died. The median time to death of 883 days (IQR 314-1270), with 7 recipients 
dying within 30 days of post-EHR discharge In an adjusted model, during the post-EHR time 
period, recipients who previously experienced EHR were 1.45-times more likely to lose their 
pancreas graft (aHR 1.171.451.80, p=0.001) and 1.46-times more likely to lose their kidney graft 
compared to recipients without EHR (aHR 1.171.461.81, p=0.001) (Table 5.2). During the post-EHR 
time period, there was no difference in the hazard of mortality comparing recipients who 
previously experienced EHR to recipients without EHR (aHR 0.991.251.57, p=0.055).  
 
DISCUSSION 
In this national study of 3,54 SPK recipients, we found that that EHR is associated with LHR, 
pancreas graft loss, kidney graft loss, and mortality. We also found that the association between 
EHR and adverse transplant outcomes is dynamic. During the readmission hospitalization, 
pancreas graft loss was 14.2-times higher and kidney graft loss was 18.4-times higher. Similarly, 
mortality was 8.5-times higher. Immediately following readmission discharge, the hazard of graft 
loss remained elevated, but much less so. Pancreas graft loss was 1.45-times higher and kidney 
graft loss was 1.46-times higher. Post-EHR there was no difference in the hazard of mortality for 
recipients who previously experienced EHR compared to recipients without EHR.  
 
Our study is the first to quantify the association between EHR following SPK and adverse clinical 
outcomes. We found that EHR is associated with a higher risk of LHR, graft loss, and mortality, 
which is consistent with our previous work on EHR following KTA. In our previous work on 
EHR following KT, we found that EHR was associated with a 3.02-fold increase in the risk of 
LHR, a 1.43-fold increase in the risk of graft loss, and a 1.50-fold increase in the risk of mortality 
(2). Following a variety of other surgical procedures, such as pancreatectomy, coronary artery 
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bypass grafting, orthopedic surgery, colectomy, and cancer resection, the hazard of mortality 
associated with EHR ranges from 2.3 to 6.6 (41, 42, 46-49, 51). However, prior work on the 
association between EHR and mortality may be misleading. These studies average the risk 
attributable to EHR over the entire follow-up period. The risk of mortality for patients who are 
acutely ill and readmitted to the hospital is assumed to be the same as the risk of mortality for a 
patient that previously experienced EHR, survived, and may be months or years post-EHR. Our 
study of EHR following SPK provides an understanding of the timeline of risk, showing that that 
the risk is highest during the EHR hospitalization and decreases substantially post-EHR.  
 
Our findings may have practical implications for management of SPK recipients experiencing 
EHR. The readmission hospitalization represents a high-risk event in the post-SPK timeline. 
Overall, recipients experiencing EHR should be managed cautiously. Our findings suggest that 
pancreas graft loss is more likely to occur during the first week of EHR hospitalization. Early and 
frequent surveillance of pancreas graft function following transplant discharge may help mitigate 
this risk. In addition, we found that kidney graft loss and mortality occurred much later into the 
EHR hospitalization. In recipients with prolonged EHR hospitalization, more aggressive 
management may help rescue these individuals. Following readmission discharge, the risk of 
graft loss was attenuated, but did not disappear completely. More importantly, a small proportion 
of recipients that were previously readmitted lost their graft or died within 30 days of the 
readmission discharge. Comprehensive discharge planning, frequent outpatient follow-up, and 
regular communication between the recipient and transplant providers may help decrease the risk 
immediately post-EHR.  
 
Our study had several notable limitations. EHR was ascertained using Medicare claims data and 
therefore our study population is limited to Medicare-primary KT recipients. Medicare is the 
leading primary insurer for nearly half of all KT recipients. Our study captures an important, and 
85	
	
large, portion of KT recipients nationally. Furthermore, all individuals with end stage renal 
disease are eligible for Medicare, regardless of age or disability. Another limitation of using 
national registry data is that we are unable to determine whether recipients lost their graft during 
the readmission or if they were readmitted because they were already losing their graft. This is a 
concern for pancreas graft loss since 6 recipients lost their graft on the day of readmission and 
75% lost their graft within the first 7 days. It is less of a concern for mortality and kidney graft 
loss, which on average occurred much later into the EHR hospitalization. Although we cannot 
prove a causal pathway between EHR and adverse outcomes, our study is the first to explore the 
attributable risk associated with EHR following SPK.  
 
Early hospital readmission is common following SPK and it portends a substantial risk of graft 
loss and mortality. Recipients experiencing EHR should be managed with caution, as they are 




Table 5.1: Study population characteristics, by early hospital readmission, n=3,054.  








Median Age, IQR (years) 40, 34-46 39, 33-46 0.04 
Female, % 34.8 35.7 0.6 
African American race, % 18.3 22.0 0.004 
Recipient BMI (kg/m2), % 
  Underweight (<18.5) 
  Normal (18.5-25) 
  Overweight (25-30) 












Mean dialysis vintage, IQR (years) 2.2, 1.2-3.5 2.2, 1.2-3.5 0.6 
Mean ESRD time, IQR (years) 2.5, 1.4-3.8 2.4, 1.4-3.7 0.3 
Median donor age, IQR (years) 23, 18-31 23, 18-33 0.2 
Female donor, % 30.7 30.9 0.8 
African American donor 13.8 18.9 <0.001 
Asian donor 1.7 2.5 0.1 
Donor BMI (kg/m2), % 
  Underweight (<18.5) 
  Normal (18.5-25) 
  Overweight (25-30) 












Median donor height, IQR (meters) 1.7, 1.7-1.8 1.7 , 1.7-1.8 0.8 
Donation after cardiac death 1.9 2.1 0.7 
Donor Cause of Death, % 
   Anoxia 
   Cerebrovascular Accident 
   Head Trauma 












Terminal creatinine >2.5 mg/dL, % 0.7 1.2 0.1 
Median length of stay, IQR (days) 9, 7-13 9, 8-14 0.03 
HLA match, % 
   0 
   1 
   2 
   3 
   4 
   5 


















Median Cold Ischemia Time, IQR 
(hours) 






Table 5.2: Hazard of death-censored graft loss and mortality during readmission hospitalization 
(readmission hospitalization) and following readmission discharge (post-readmission). 
 





Pancreas graft loss 7.8014.225.8 1.171.451.80 
Kidney graft loss 5.3418.463.2 1.171.461.81 
Mortality 2.088.534.8* 0.991.251.57** 






DISCUSSION AND FUTURE PLANS 
 
Through this thesis work, we have examined clinical mechanisms, novel predictors, and the time-
varying impact of EHR following kidney transplantation and simultaneous pancreas-kidney 
transplantation. We built a framework for the development of clinical practices aimed at 
preventing readmission. WE have also provided valuable knowledge for clinical decision making 
for recipients experiencing EHR.  
 
First, we used granular single-center data to characterize the clinical scenarios in which EHR 
occurs at our own transplant center. We showed that the majority of readmissions occur directly 
to the hospital without prior evaluation by a healthcare provider. We showed that infection was 
the most common reason for readmission, with the urinary tract as the most likely source. We 
also found that a subset of readmissions were more complex and not due to one primary reason. 
At our center, which performs many transplants with desensitization and has an infrastructure 
established for these complex recipients, we found no difference in the rate of readmission 
comparing desensitized recipients to other recipients. We observed no association between EHR 
and HRQOL, cognitive function, functional status, or physical function. A potential explanation 
is that kidney transplant recipients are selected based on many of these variables and our KT 
population overall had high HRQOL and high cognitive and physical function. We also found no 
association between EHR and socioeconomic factors. A potential explanation is that the decision 
to readmit is based on clinical characteristics rather than socioeconomic factors. A second 
explanation may be that all KT recipients, regardless of socioeconomic factors, are closely 





We next used national registry data to explore the association between EHR and social 
determinants of health. Again, we found no association between EHR and socioeconomic status. 
We explored the independent association between EHR and community risk and found that the 
health behaviors of individuals living near KT recipients are associated with EHR. Recipients 
living in low-intermediate, high-intermediate, and highest risk communities were at increased risk 
of readmission. In addition, EHR was inversely associated with distance from transplant center. 
Recipient living within 10 miles of their transplant center were at highest risk of readmission. 
These findings support our hypothesis that factors above and beyond clinical characteristics 
contribute to EHR and should be considered in strategies to predict and reduce EHR.  
 
Next, we explored the time-varying impact of EHR. We determined the hazard of graft loss and 
mortality associated with EHR during two distinct time periods: the EHR hospitalization and 
post-EHR. We hypothesized that the risk would be higher during the EHR hospitalization and 
would decrease post-EHR. We showed that compared to recipients without EHR, recipients 
experiencing EHR were at a substantially higher risk of both graft loss and mortality during the 
EHR hospitalization. Immediately following EHR discharge, the risk dropped substantially. 
However, compared to recipients without EHR, recipients that previously experienced EHR 
remained at an elevated risk of both graft loss and mortality for approximately 5 years following 
readmission.  
 
We also used national registry data to explore EHR following SPK. We found that 54% of SPK 
recipients experience EHR, a much larger proportion compared to KT alone, likely owing to the 
increased surgical complexity of SPK. Few patient-level characteristics were associated with 
EHR, making it difficult to predict which SPK recipients are at highest risk. Younger SPK 
recipients were at an increased risk of EHR, making this population a potential sub-group to 
target. Younger recipients may benefit from detailed discharge planning and more frequent 
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outpatient follow-up. The most common reasons for readmission were infection, kidney/urinary 
tract disorder, and pancreatic/hepatobiliary disorder. Prompt management of these conditions may 
prevent more serious complications in the long-term. 
 
Finally, we found that EHR substantially increases the risk of both pancreas and kidney graft loss 
during the EHR hospitalization, and that risk drops substantially following readmission discharge. 
We also found that EHR is associated with an increased risk of mortality during the EHR 
hospitalization. However, compared to recipients without EHR, there was no difference in the 
risk of mortality post-EHR. These findings suggest that recipients experiencing EHR following 
SPK should be managed with caution as they are more susceptible to adverse outcomes both 
during the EHR hospitalization and post-EHR. Aggressive management during the EHR 
hospitalization, as well as detailed discharge planning, frequent follow-up, and open 
communication between the recipient and the transplant team may help decrease the risk of 
adverse outcomes during the EHR hospitalization and post-EHR.  
 
Our findings build the foundation for future work, which will focus on preventing unnecessary 
readmission and improving patient outcomes for recipients that experience EHR. Within our own 
center, prevention and early rescue of infection may be an area for potential impact. During the 
initial transplant hospitalization, prior to discharge, and throughout early outpatient follow-up, 
our transplant providers can have a high index of suspicion and a low threshold to treat infection. 
An important finding at our center was that the majority of readmissions occurred directly from 
home. We plan to implement an outpatient area, separate from our regularly scheduled clinics, 
where a transplant provider can evaluate transplant patients with acute issues. This would 
facilitate early diagnostic testing and may even enable a cost-effective forum for treatment of low 
acuity conditions. An intermediate level of evaluation, prior to readmission, would allow our 
transplant providers to collect information and make an informed decision about the need for 
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hospitalization. In addition, earlier evaluation by a transplant provider would eliminate any delay 
in management for recipients presenting with critical issues.  
 
In addition to developing interventions to address EHR at our own center, we plan to further 
explore the impact of social determinants of health on readmission following SPK. Ultimately, 
our goal is to build a comprehensive, easy to use, risk prediction tool for EHR. Using our existing 
national models, which incorporate both clinical and social characteristics, we will classify 
recipients as low, intermediate, or high risk of EHR. We will then prospectively test the 
discriminative ability of our prediction tool in a cohort of kidney transplant recipients at our own 
transplant center. If effective, recipients at high risk of experiencing EHR could be assigned more 
frequent outpatient clinic visits, regular phone calls from a provider, and a specific list of clinical 
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